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CHAPTER 1. GENERAL INTRODUCTION 
Molecular oxygen, as the final electron accepter of aerobic respiration, is essential for 
the survival of most metazoans. Oxygen deprivation (hypoxia) is often involved in 
development, homeostasis and many diseases. In order to adapt to hypoxia, multi-cellular 
organisms have evolved complex networks that regulate metabolic changes in both systemic 
and cellular levels to mediate changes in angiogenesis/ vascular remodeling, glycolytic 
metabolism and cell proliferation (HOPKINS and POWELL 2001). Many of these metabolic 
changes are also involved in aging, suggesting that hypoxia response signaling may be 
intertwined with the pathways modulating aging. The hypoxia-inducible factor (HIF) 
transcription factor is a master regulator that mediates most of the transcriptional changes 
during hypoxia adaptation. Recent studies have suggested that HIF can influence replicative 
senescence in mammals (KATSCHINSKI 2006), but the roles of HIF in aging are not fully 
understood. 
The C.elegans hif-1 gene is orthologous to mammalian HIF-1 α genes. C. elegans has 
proven to be a premier model for studying aging (OLSEN et al. 2006) and also a powerful 
system for deciphering the regulation and function of HIF (EPSTEIN et al. 2001; SHEN et al. 
2006). In this dissertation research, I studied the roles of HIF-1 and hypoxia response in 
organismal aging in C.elegans. My results established HIF-1 as an important modulator of 
aging in C.elegans. I discovered that both HIF-1 over-expression and hif-1 loss-of-function 
mutations extend life span. I further demonstrated that hypoxia treatment promotes longevity 
in C.elegans. My studies also provided evidence for HIF-1-independent pathways for 
hypoxia response to modulate aging. Finally, using forward genetic approaches, I identified a 
novel protein that regulates the activity of C. elegans HIF-1 in mechanisms distinct from the 
VHL-1-dependent proteosomal degradation pathway. I have divided the literature review into 
two major sections: aging and hypoxia.  
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LITERATURE REVIEW 
AGING: LESSONS FROM STUDIES OF C. elegans 
Why must we age? This is a question that interests most individuals at some time in 
their lives. Therefore, it is not surprising that aging is one of the most intriguing fields to the 
public. As human life expectancy continues to increase, age-related disorders, such as cancer, 
diabetes, cardiovascular and neurodegenerative diseases are among the biggest threats to 
human health. Understanding the molecular processes that govern aging holds the promise to 
develop novel treatments for these disorders. 
In the past 20 years, studies of aging in invertebrate model organisms, including 
Caenorhabditis elegans, have provided key insights into the genes and gene networks that 
modulate aging. Since the discoveries in 1980s that mutations in single genes could 
significantly extend life span in C. elegans, hundreds of single-gene mutations have been 
found to increase longevity in nematodes, yeast and fruit flies. This is especially interesting 
because many of the pathways that modulate aging are conserved across species as diverse as 
nematodes and humans. There is great hope that these discoveries will translate to advances 
in human medicine, but major questions remain. For example, reduction-of-function 
mutations in daf-2, an insulin/IGF-1 recepter orthologue, double the life span in C.elegans 
(KENYON et al. 1993). Can we expect that interventions that inhibit insulin/IGF-1 pathway in 
humans will yield similar results? Also, in terms of deciphering how age-related diseases 
intersect with basic aging processes, how much we can learn from the model systems about 
age-related diseases in humans? In this literature review, I discuss some of the processes that 
are central to aging and review some of the important insights provided by studies in 
C.elegans. 
The senescence of mitotic cells: when regeneration matters 
Aging is a fundamental process with great natural diversity. Considering the longevity 
of nematodes (weeks) and mammals (years), it is fascinating to ask what enables humans to 
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live for decades, while nematodes live only for weeks? At present, a comprehensive answer 
to this question is yet to be found. However, cell replacement and regeneration may be major 
contributors. In mammals, many somatic tissues, to various degrees, have the capacity to 
replace the cell loss with proliferation of mitotic cells. This mechanism to maintain the 
integrity of tissues and organisms is totally absent in C. elegans, in which all somatic cells of 
adults are post-mitotic. The evolution of stem cells that renew, repair, and in some cases, 
regenerate somatic cells has enabled complex organisms, like humans, to live longer. 
However, as demonstrated by Hayflick and colleagues more than 40 years ago, normal 
mitotic cells only had limited abilities to proliferate in culture (HAYFLICK 1965). In their 
classic experiment, they found that explanted human fibroblasts, after around 50 cell 
doubling, gradually lost their ability to divide. This phenomenon was termed as cellular 
senescence. Substantial evidence from recent studies suggested that cell senescence also 
occurs and is important to aging in vivo (CAMPISI and D'ADDA DI FAGAGNA 2007). Using 
senescence-associated markers, senescent cells were found in many renewable tissues in 
rodents, primates and humans, and their numbers increase with age (DIMRI et al. 1995; 
JEYAPALAN et al. 2007; KRISHNAMURTHY et al. 2004). It has been suggested that 
senescence-associated suppression of stem-cell proliferation and tissue regeneration may be a 
major cause of aging (JANZEN et al. 2006; KRISHNAMURTHY et al. 2006; MOLOFSKY et al. 
2006). 
Once cellular senescence was discovered, people began to ask what selective pressure 
might contain mitotic cells from unlimited replication. Although increases in 
post-reproductive longevity may provide little evolutionary benefit for most animal 
populations, increased ability to heal and repair tissues through unlimited cell replacement 
and regeneration would seem to provide huge advantage in fitness of natural selection. Yet 
evolution has selected the opposite. The predominant theory is that cellular senescence has 
evolved as a mechanism to suppress the tumor formation (BRAIG and SCHMITT 2006; 
CAMPISI 2001; SAGER 1991). Although cell proliferation is essential for tissue renewal in 
complex organisms such as mammals, it also increases the risks of acquiring and 
subsequently propagating mutations. Senescence limits the number of times each mitotic 
cells can replicate and limits tumor growth. The inextricable link between senescence and 
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tumor suppression is highlighted by the finding that transgenic mice with constitutively 
hyperactive forms of p53, a major tumor suppressor gene, were remarkably tumor-free, but 
also displayed accelerated aging phenotypes (MAIER et al. 2004; TYNER et al. 2002). 
The plasticity of aging in post-mitotic cells 
Organismal aging is also determined by the lifespan of post-mitotic cells. Therefore, it 
is important to consider the aging process in post-mitotic cells. Post-mitotic cells are those 
that have irreversibly exited from the cell cycle and have undergone terminal differentiation. 
In mammals, post-mitotic cells include neurons, muscle cells, osteocytes and blood cells that 
comprise much of the brain, heart and skeletal muscle, bone and circulatory system. In 
addition, since many cells capable of mitosis (tissue specific stem cells or progenitor cells) 
are mostly quiescent, many of the factors that contribute to aging of post-mitotic cells are 
also applied to mitotic cells (DRUMMOND-BARBOSA 2008; PAN et al. 2007b). This allows 
post-mitotic cells as a good model to study aging at cellular level. 
The lifespan of post-mitotic cells vary widely. For example, in adult C. elegans, where 
all somatic tissues are post-mitotic, aging is characterized by a progressive deterioration of 
muscle cells while the nervous system is largely preserved (HERNDON et al. 2002). The 
comparison is more staggering if we consider human neurons, which can function throughout 
human life. 
Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s 
diseases (PD) are tightly linked to the aging of human neurons. The incidence of these 
diseases increases dramatically with age. Although the etiologies of these devastating 
diseases are not fully understood, they may be initiated by normal aging processes and 
accelerated by adverse genetic or environmental conditions (MATTSON and MAGNUS 2006). 
Some of the factors that contribute to neurodegeneration also influence aging of other tissues, 
such as heart and muscle (CHIEN and KARSENTY 2005). So there is real synergism between 
these related fields. Moreover, some risk factors of neurodegenerative diseases turn out to be 
major components in modulating aging in C.elegans (see detailed discussion below). 
Therefore, despite the huge difference between the longevity of human neurons and 
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C.elegans somatic tissues, some common themes in the basic biology of aging appear to be 
conserved. 
Mitochondria and oxidants: the enemy within 
According to the free radical theory of aging, macromolecular damages generated by 
reactive oxygen species (ROS) accumulate throughout the life and cause aging (BECKMAN 
and AMES 1998).  Given that aerobic metabolism in mitochondria is the main source of 
ROS, mitochondria play uniquely important roles in aging as well as in neurodegenerative 
diseases.  
Mitochondrial dysfunction has long been associated with the pathogenesis of PD. 
Impairment of mitochondrial respiration by inhibiting complex I in dopaminergic neurons 
results in increased ROS and oxidative damage to the cell (VILA and PRZEDBORSKI 2003). 
Oxidative damage may accrue and ultimately trigger mitochondria-dependent programmed 
cell death, which is critical to PD-related dopaminergic neurodegeneration (DAUER and 
PRZEDBORSKI 2003; VILA and PRZEDBORSKI 2003). Recent studies have demonstrated that 
many proteins involved in familiar forms of PD, such as PTEN-induced kinase 1, parkin, 
alpha-synuclein, directly or indirectly interact with mitochondria (VILA et al. 2008). 
Intriguingly, mitochondrial dynamics, the regional distribution of mitochondria within 
neurons, also appear to be important in neurodegenerative diseases. It has long been known 
that a large number of mitochondria localize at the pre-synaptic terminals. This regional 
enrichment of mitochondria reflects the high energy demand during synaptic activity, but 
may also restrict the ROS generation and molecular damage. In healthy neurons, 
mitochondria are actively transported to axon terminals. The impairment of mitochondrial 
axonal transport can be an important contributor to many neurodegenerative disorders 
(MAGRANE and MANFREDI 2009).  
Perturbations of mitochondrial genes have profound impacts on aging of C. elegans. 
Some mutations of the respiratory chain in C.elegans, such as mev-1(succinate 
dehydrogenase cytochrome b), shorten lifespan presumably by increasing ROS levels (ISHII 
et al. 1998). Conversely, a mutation in isp-1, which encodes a component of respiratory 
chain complex III, extends life span (FENG et al. 2001). Likewise, knocking down more than 
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a dozen of mitochondrial components by RNAi in C. elegans increases lifespan, probably 
through reducing ROS generation (DILLIN et al. 2002b; LEE et al. 2003b). Indeed, Rea and 
Johnson noted that many of the mutations that increased longevity in C. elegans were 
predicted to divert cellular metabolism from the classic TCA and electron transport chain to 
alternative energy-producing pathway (REA and JOHNSON 2003). However, it is worth noting 
that due to the lack of techniques to measure the ROS level in vivo, the causal relationship 
between ROS generation and altered lifespan in C.elegans still waits to be determined.  
Maintenance and repair programs: roles of stress response transcription factors 
ROS are by-products of respiration and other metabolic processes and also serve as 
signaling molecules (FINKEL 2003). Although diverting from classic aerobic respiratory 
metabolism may decrease ROS generation and extend lifespan, it compromises the efficiency 
of energy production and may decrease the overall fitness of the organism. Therefore, 
organisms must adapt to certain levels of ROS and evolve processes to attenuate the damages 
that ROS cause. During evolution, maintenance and repair programs have been developed to 
counteract these damages, and increased ability to limit macromaolecular damage may 
postpone aging. 
Increased oxidative stress is associated with many neurodegenerative diseases, such as 
PD, AD, Huntington’s diseases and amyotrophic lateral sclerosis. In response to oxidative 
stress, the Nrf-2 transcription factor activates a group of anti-oxidant genes, including 
cystine/glutamate antiporter and glutathione peroxidase to protect cells from oxidative stress 
induced cell death (KANG et al. 2005; QIANG et al. 2004). Drug induced activation of Nrf-2 
protects mice from insults of mitochondrial inhibition (SHIH et al. 2005). Conversely, Nrf-2 
deficient mice are significantly more vulnerable to oxidative stress induced by mitochondrial 
complex I and II inhibition (CALKINS et al. 2005). 
Some of the key regulators of macromolecular maintenance and repair have been 
shown to modulate post-mitotic aging. Some transcription factors, exemplified by 
DAF-16(FOXO), HSF-1(heat shock factor), SKN-1 (Nrf-2-like), orchestrate large sets of 
genes that modulate stress response, as well as overall metabolism (HSU et al. 2003; LEE et al. 
2003a; MCELWEE et al. 2003; MORLEY and MORIMOTO 2004; MURPHY et al. 2003; TULLET 
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et al. 2008). Among these stress response genes are a handful of antioxidant enzymes, such 
as glutathione peroxidase, glutathione reductase, superoxide dismutase (SOD) and catalase. 
Another category of genes being activated by stress response transcription factors are 
chaperones that mediate protein homeostasis. Interestingly, while each antioxidant enzyme or 
chaperone may only make a minor contribution to longevity in C. elegans, mobilizing a 
cohort of these genes by activating stress response transcription factors dramatically 
increases lifespan. For example, using microarray analysis, Murphy et al. identified a group 
of stress response genes that are up-regulated in animals that carried a reduction-of-function 
mutation in daf-2. Of these, they focused on the genes that were positive regulated by 
DAF-16/FOXO. While a loss-of-function mutation of daf-16 completely abolishes the 
longevity of daf-2 mutant worms, knocking down individual daf-16-dependent stress 
response genes by RNAi shortened lifespan of daf-2 mutants between 10-20% (MURPHY et al. 
2003). Conversely, animals carrying additional hsf-1 gene copies lived ~40% longer than 
normal (HSU et al. 2003) while over-expression of small heat-shock protein gene hsp-16, 
which is induced by HSF-1, extended life span ~ 10% (WALKER and LITHGOW 2003) 
Recycling and eliminating damaged molecules: a role of autophagy 
Accumulation of damaged proteins and organelles is a hallmark of aging and aging 
related diseases. Protein aggregations shared by neurodegenerative diseases disturb neural 
function by hampering axonal transport, synaptic integrity, and mitochondrial function 
(RUBINSZTEIN 2006). Interestingly, autopsies of healthy old person’s brain revealed as many 
protein aggregates as in AD patients, emphasizing the common biology of normal aging and 
neurodegenerative disorders (ESIRI 2001).  
Autophagy, a cellular process whereby damaged macromolecules and organelles are 
degraded and recycled for ATP and reusable building blocks, provides another example that 
studies of neurodegeneration and C.elegans longevity have merged. An increasing body of 
evidence indicates that autophagy is a critical defensive mechanism in removing protein 
aggregates in neurons. Studies that used brain-specific conditional knockouts of 
autophagy-related genes (ATG) revealed that loss of autophagy elicits protein aggregate 
formation and neurodegeneration cascade (HARA et al. 2006; KOMATSU et al. 2006). 
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Correspondingly, inducing autophagy holds a therapeutic promise to slow the neural loss in 
neurodegenerative disorders (BOSSY et al. 2008). It is also noteworthy that if pushed to the 
extreme, autophagy can be lethal to a cell, but at moderate levels, it may slow neural loss in 
neurodegenerative disorders (VENTRUTI and CUERVO 2007). 
Strong evidence has linked autophagy with aging in C.elegans. Knocking down the 
worm orthologue of beclin/ATG6 suppresses dauer formation and lifespan extension in daf-2 
mutants (MELENDEZ et al. 2003). Autophagy is strongly induced by conditions of nutrient 
limitation and is required for longevity mediated by dietary restriction in C.elegans (HANSEN 
et al. 2008; JIA and LEVINE 2007). Toth et al. proposed that autophagy, receiving signals 
from many longevity pathways, may act as a central regulatory mechanism of animal aging 
(TOTH et al. 2008). 
Organismal aging and lessons learned from long-lived mutant worms 
The results of longevity study in C.elegans are not only informative to the aging of 
post-mitotic cells, but also provide insights into the aging in the organismal level. Using 
C.elegans as a model system, it has been demonstrated that mutations of single gene can 
delay aging. Some of these long-lived mutants are astonishing: down-regulating 
insulin/IGF-1 signaling (IIS) pathway routinely increases lifespan in nematodes twofold 
(KENYON 2005), and one severe loss-of-function mutation in age-1, which encodes the 
phosphatidylinositol 3-kinase catalytic subunit, was shown to increase lifespan tenfold 
(AYYADEVARA et al. 2008). It is probably unreasonable to believe that interventions to 
inhibit the evolutionarily conserved IIS pathway can also double the life span in humans, as 
complexity of signaling pathways increase during evolution (VIJG and CAMPISI 2008). 
However, understanding the mechanisms underpinning the dramatic impact of single gene 
mutations may give us sufficient knowledge to forestall degeneration in human life. 
The first lesson we can learn from the long-lived mutant worm is that a single gene can 
orchestrate multiple mechanisms to modulate aging in cellular level. As discussed earlier, 
mitochondrial metabolism, stress response transcription factors and recycling and eliminating 
damaged proteins are major components in the cellular responses that modulate aging of 
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post-mitotic cells. Hypoporphic mutations of daf-2 induce all of these responses (Figure 1). 
In C. elegans, the insulin/IGF receptor DAF-2 regulates a handful of transcription factors, 
including DAF-16, HSF-1, SKN-1, that mediate stress response. These transcription factors 
can mobilize a large number of genes that modulate oxidative stress and protein homeostasis 
(AN and BLACKWELL 2003; HSU et al. 2003; LEE et al. 2003a; MCELWEE et al. 2003; 
MURPHY et al. 2003). DAF-16 also regulates a number of enzymes involved in mitochondrial 
metabolism in C. elegans (LEE et al. 2003a; MCELWEE et al. 2003; MURPHY et al. 2003). 
Moreover, as discussed earlier, daf-2 mutation induces autophagy, which is required for the 
life span extension in daf-2 mutants (MELENDEZ et al. 2003). 
Although cell autonomous processes like ROS neutralization and protein folding are 
central to post-mitotic aging, studies have revealed that some genes have 
non-cell-autonomous and tissue-specific roles. For example, many mutations in C. elegans 
that alter sensory perception extend lifespan (ALCEDO and KENYON 2004; APFELD and 
KENYON 1999). This longevity effect is largely daf-16 dependant (ALCEDO and KENYON 
2004; APFELD and KENYON 1999), indicating their association with insulin/IGF pathway. 
Apfeld et al, examined somatic mosaic animals and concluded that loss of daf-2 function 
from only a few neurons was sufficient to extend lifespan (APFELD and KENYON 1998). 
Some sensory neurons may influence lifespan by producing insulin-like peptides (LI et al. 
2003; MURPHY et al. 2003; PIERCE et al. 2001). Moreover, increasing DAF-16 activity in 
intestinal cells extends lifespan of worms ~50% (LIBINA et al. 2003). Interestingly, reduced 
IGF-1 signaling specifically in adipose tissue extends life span in mice (BLUHER et al. 2003). 
Therefore, tissue-specific intervention of particular signaling pathways might also slow aging 
in humans. 
Studies of long-lived mutant worms also indicate that stochastic factors are important 
in aging. In standard culture conditions, the average adult lifespan of wild-type animals is 
18-20 days. However, the first worm in a population may die at around 10 days, and the 
maximum lifespan is around 30 days. Extensive variability exists in age-related degeneration 
even among cells of the same type within an individual (HERNDON et al. 2002). Interestingly, 
senescence of mitotic cells also exhibit stochastic properties: senescent cells are present at 
early passage cultures and their percentage gradually increases with each serial passage in the 
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culture (CRISTOFALO and SHARF 1973). Even two cells derived from a single mitosis 
displayed variation in their ability to proliferate (JONES et al. 1985). 
Conclusions 
The prevalent theories on aging suggest that the aging results from the damage that is 
the natural consequence of normal metabolic processes and of less predictable stresses. The 
rates of damage and of cellular or tissue repair are influenced by environmental or genetic 
variables. 
In this review, I discussed some common themes from studies that have analyzed the 
genetic basis of aging. Mutations that extend lifespan often 1) to decrease the production of 
ROS, the major source of molecular damages, mainly through modulating mitochondrial 
activity; 2) to increase cellular resistance to stresses, often by regulating some stress response 
transcription factors; 3) to eliminate damaged molecules and to reallocate energy resources to 
the maintenance and repair machinery from other cost processes, such as reproduction and 
growth. Importantly, these principle components are often orchestrated at cellular level as 
well as in tissue and organ system to regulate organismal aging.  
Complex animals, like mammals, also recruit cell replacement to maintain the integrity 
of tissues and organisms, to counteract aging. However, this strategy also puts the animals in 
danger of cancer. Cellular senescence limits potential for tumor growth, but may also 
expedite aging. 
In attempts to apply these strategies for human lifespan extension, however, it should 
be kept in mind that although many pro-aging pathways are evolutionarily conserved, the 
results of interventions that target these pathways may be different in different species as 
well as in different tissues. For example, while activation of DAF-16 dramatically increases 
lifespan in C. elegans, no correlation has been identified in other variants of FOXO genes to 
survival at older age in humans. Moreover, while activation of FOXO3 induces autophagy in 
muscle cells, it leads to apoptosis in neurons in mammals (GILLEY et al. 2003; LEHTINEN et 
al. 2006; MAMMUCARI et al. 2007; SHINODA et al. 2004). Nonetheless, a more complete 
understanding of aging mechanisms and their relationships to age-related diseases (i.e. cancer, 
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diabetes, cardiovascular and neurodegenerative diseases) will allow us to develop 
sophisticated and integrative interventions to increase human health. 
 
HYPOXIA RESPONSE AND HYPOXIA-INDUCIBLE FACTOR 
The survival of all metazoans depends on the utilization of molecular oxygen to 
maintain the intracellular bioenergetics. During development, homeostasis as well as many 
pathological conditions, such as tumor, ischemia and stoke, cellular oxygen levels often do 
not meet the physiological demand. This condition is termed as hypoxia. The intensive study 
of hypoxia began as early as 100 years ago when Schwarz and colleagues noticed that normal 
mammalian cells under hypoxia were less sensitive to irradiation than those irradiated in the 
presence of O2 (CHURCHILL-DAVIDSON et al. 1955). This resistance effect was later also 
identified in human tumors, and varying O2 concentration has since then been associated with 
significantly different effects on cellular processes (SIMON et al. 2008). Notably, hypoxia 
profoundly influences the properties of tumors, from proliferation and angiogenesis to 
irradiation and chemotherapy resistance. To understand the molecular mechanisms behind 
these effects has been the main focus of hypoxia research. 
Discovery and molecular cloning of hypoxia-inducible factors 
The cloning of hypoxia-inducible factor 1 (HIF-1) is the cornerstone in elucidating the 
mechanisms by which animal cells sense O2 tension and regulate transcription in hypoxia 
(WANG et al. 1995). HIF-1 are heterodimeric transcription factor composed of a α and a β 
subunit. Both subunits are members of the basic helix-loop-helix (bHLH) transcription factor 
family that contains PAS domain (the name PAS comes from the initial characterization of 
the domain in Drosophila melanogaster protein PER and SIM and the mammalian protein 
aryl hydrocarbon nuclear translocator (ARNT)). While HIF-1β subunit, also known as 
ARNT, is generally expressed, the stability of HIF-1α subunit is tightly controlled by cellular 
oxygen level (JIANG et al. 1996). 
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The dimeric HIF-1 complex binds to conserved Hypoxia-Response-Element (HRE) 
(5’-G/ACGTG-3’) that is associated with numerous transcriptional target genes mediating 
hypoxia response. In mammals, HIF induces genes like VEGF and EPO, which are involved 
in systematic hypoxia response, such as angiogenesis/vascular remodeling and erythropoiesis. 
A large number of HIF target genes are associated with cellular hypoxia responses, such as 
metabolism, proliferation, migration and autophagy. (WOUTERS and KORITZINSKY 2008). 
The complexity of HIF arises as the discovery of the HIF-1α paralogues. HIF-2α (also 
known as endothelial PAS domain protein 1) is also oxygen-regulated and can dimerize with 
HIF-1β. HIF-1α and HIF-2α activate transcription of an overlapping but distinct set of genes 
(WANG et al. 2005). Another paralogue, HIF-3α was found to inhibit the transcriptional 
activity of HIF-1α by competing with HIF-1β (MAKINO et al. 2001).  
The significance of the transcriptional changes regulated by HIF is highlighted by the 
tight association of HIF activation and cancer progression (GIACCIA et al. 2003; MAXWELL et 
al. 2001; SEMENZA 2003). Immunohistochemistry has revealed HIF accumulation in a broad 
array of human malignancies (MAXWELL et al. 2001). This accumulation has been associated 
with poor prognosis in breast cancer (BOS et al. 2001; SCHINDL et al. 2002), cervical cancer 
(BIRNER et al. 2000), ovarian cancer (BIRNER et al. 2001) and neuroblastoma 
(HOLMQUIST-MENGELBIER et al. 2006). Conversely, downregulating HIF, either by inhibiting 
translation or promoting degradation, or inhibiting key HIF target genes, such as VEGFA, 
have proven to be promising interventions for anti-cancer therapies (GIACCIA et al. 2003; 
SEMENZA 2003).  
Jiang et al. found HIF transcriptional complex was conserved in nematodes C. elegans 
(JIANG et al. 2001). Nematodes C.elegans consist of fewer than one thousand cells and do not 
have a complex circulatory system. The small body of the C.elegans enables the cells to 
obtain oxygen from diffusion. In natural habitat, C.elegans experience hypoxia when they 
burrow into soil searching for food. The identified C.elegans HIF complex consists of HIF-1 
and AHA-1, which are C. elegans orthologues of HIF α and β subunits, respectively (JIANG 
et al. 2001; POWELL-COFFMAN et al. 1998). While AHA-1 expression did not change with 
oxygen level, HIF-1 was induced by hypoxia but quickly reduced upon reoxygenation 
(EPSTEIN et al. 2001; JIANG et al. 2001). HIF-1 regulates the majority of early transcriptional 
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changes in response to hypoxia (SHEN et al. 2005). Loss-of-function hif-1 mutant worms 
show decreased ability of hypoxia adaptation (JIANG et al. 2001). The conservation of HIF 
signaling makes C. elegans, with its powerful genetics, an attractive model in search of genes 
regulating HIF. 
Regulation of HIF 
Oxygen-dependent degradation of HIF 
The discovery of EGLN prolyl hydroxylase family is a wonderful example to use C. 
elegans as a model system in dismantling the mechanism of HIF regulation. After the 
molecular characterization of the HIF1 complex in mammals, direct analysis of HIF1α 
subunit revealed that it is ubiquitinated and degraded by 26S proteasome in normoxia 
(HUANG et al. 1998; KALLIO et al. 1999; SALCEDA and CARO 1997). The next big step in 
elucidating the regulation of HIFα stability was the identification of the von Hippel-Lindau 
tumor suppressor (VHL) as the substrate recognition component of a ubiquitin ligase 
complex that targeted HIF1α for proteasomal degradation (COCKMAN et al. 2000; KAMURA 
et al. 2000; MAXWELL et al. 1999; OHH et al. 2000). However, one critical question remained: 
what was the oxygen sensor and how does it function to control HIF α stability? 
To answer this question, the Ratcliffe group demonstrated that in C. elegans, the role 
of vhl-1, a homolog of VHL, in regulating HIF-1 stability was conserved (EPSTEIN et al. 
2001). They then found that in a C. elegans mutant of egl-9, which encodes a 2-oxoglutarate 
dioxygenase, HIF-1 protein was constitutively stabilized (EPSTEIN et al. 2001). A family of 
egl-9 homologs, termed as prolyl hydroxylase domain (PHD) 1, PHD2 and PHD3, was 
subsequently identified in human and mice (EPSTEIN et al. 2001). Elegant biochemical 
studies demonstrated that the interaction between HIF-1α and VHL requires the 
hydroxylation of specific proline residue within the evolutionary conserved 
oxygen-dependent-degradation (ODD) domain in HIF-1α subunit (IVAN et al. 2001; 
JAAKKOLA et al. 2001; YU et al. 2001). PHDs were characterized as the enzymes that 
catalyze this reaction. Using oxygen and 2-oxoglutarate as co-substrate, iron and ascorbate as 
cofactors, PHDs sense the intracellular O2 tension as well as aerobic metabolites to regulate 
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the degradation of HIF-1α subunit (BRUICK and MCKNIGHT 2001; EPSTEIN et al. 2001; IVAN 
et al. 2002). 
Interestinly, PHD2 and PHD3 genes contain hypoxia response elements and are 
induced by HIF-1 during hypoxia (MARXSEN et al. 2004; METZEN et al. 2005; STIEHL et al. 
2006). In C.elegans, expression of egl-9 mRNA was found to be induced by hypoxia in a 
hif-1-dependent manner (SHEN et al. 2005). Therefore, HIF-1/PHD/pVHL forms a 
evolutionarily conserved negative feedback loop to regulate the oxygen homeostasis. 
Degradation independent regulation of HIF 
Regulation of HIF also occurs at levels independent of HIFα stability. For example, in 
mammals, Factor inhibiting HIF (FIH) mediates hydroxylation of an asparagines residue in 
the carboxy-terminal of the HIFα subunit, which blocks its interaction with transcription 
co-activator p300 (C/EBP). This results in the attenuation of HIF transcriptional activity 
(LANDO et al. 2002). Interestingly, like PHDs, FIH is also an iron and 2-oxoglutarate 
dependent dioxygenase. This renders FIH a O2-senser to fine-tune the regulation of HIF 
activity (MAHON et al. 2001). 
Apart from serving as an O2-sensor in oxygen-dependent degradation, 
VHL-independent functions of PHD in regulating HIF activity have been documented. To 
and Huang demonstrated that PHD2 could inhibit HIF-1 transcriptional activity in vhl-/- cells 
(TO and HUANG 2005). Moreover, there is evidence that in Hela cells PHD2 can recruit ING4 
tumor suppressor to the promoter region of HIF-1 target gene to inhibit HIF-1 transcriptional 
activity (OZER et al. 2005). The interaction between PHD and HIF alpha may be complex 
and need other co-factors, as demonstrated by Hopfer et al. that PHD3 required Morg1 
(MAPK organizer 1), a WD-repeat protein, to repress HIF1 activity (HOPFER et al. 2006). 
The degradation-independent role of EGL-9 is evidently conserved in C.elegans. When 
comparing the egl-9 -/- and vhl-1 -/- phenotypes, Shen et al. found that egl-9-/- mutation had 
much stronger effect on the expression of HIF-1 target genes, while the HIF-1 protein level is 
quite similar in both mutants (SHEN et al. 2006). Ratcliffe’s lab has shown that in contrary to 
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the fact that egl-9 RNAi increased the expression of a HIF target gene in vhl-1 mutant worms, 
the dioxygenase inhibitors did not, which suggest that some of the inhibition effect of EGL-9 
may be independent of its catalytic activity (BISHOP et al. 2004). Although homologs of 
genes involved in VHL-independent function of EGLNs, such as ING4 and Morg1, may 
exist in C. elegans genome, their roles in regulating HIF-1 activity have not been determined. 
Other hypoxic response signaling pathways 
Other pathways also contribute to hypoxia response, although they are not as well 
understood as the HIF pathway. More recently, two additional pathways have been proved to 
be involved in hypoxia response to influence gene expression and cell behavior in mammals.  
The first is through the regulation of the kinase mammalian target of rapamycin 
(mTOR). mTOR, as part of mTOR complex (mTORC), integrates growth and metabolic 
signals and controls the translational machinery through its ability to phosphorylate 
ribosomal protein S6 kinase (p70S6K), eukaryotic elongation factor 2 kinase (eEF2 kinase) 
and eukaryotic translation initiation factor 4E (eIF4E) binding protein 1 (4E-BP1) (HAY and 
SONENBERG 2004). Hypoxia inhibits mTOR through multiple pathways, and final outputs are 
reducing protein synthesis and inducing autophagy and/or apoptosis (for reviews, see 
(WOUTERS and KORITZINSKY 2008). 
In addition to inhibit mTOR pathway, recent studies indicate that hypoxia can also 
induce endoplasmic reticulum (ER) stress and subsequently activate the unfolded protein 
response (UPR) (RON and WALTER 2007). Although little is known about the molecular 
mechanisms, hypoxia activates several ER stress sensors, such as PERK (PKR-like ER 
kinase) and IRE1 (inositol-requiring protein1) (Koumenis et al. 2002; ROMERO-RAMIREZ et 
al. 2004). Consequently, the effector pathways of UPR inhibit mRNA translation to prevent 
further accumulation of unfolded proteins in ER, and also induce ER-associated degradation 
(ERAD) and autophagy to remove misfolded proteins (BERNALES et al. 2006; KOUMENIS et 
al. 2002; OGATA et al. 2006). Both TOR and UPR pathways are largely conserved in C. 
elegans (JIA et al. 2004; SHEN et al. 2001). However, their roles in hypoxia response in C. 
elegans are still not clear. 
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Hypoxia response signalings other than HIF-1 pathway are present in C.elegans. Using 
cDNA microarray analysis, Shen et al. identified 110 hypoxia-regulated genes in C.elegans. 
Among these genes, 47 genes are regulated independently of hif-1 function (SHEN et al. 
2005). In the same study, the authors also found that daf-16, a forkhead transcription factor, 
are induced by hypoxia independently of hif-1. DAF-16 is well-known for its function in 
insulin/IGF-1 like signaling pathway to regulate dauer formation, stress resistance and 
longevity. Correspondinly, loss-of-function mutation of daf-2, an insulin/IGF-1 like receptor, 
has been found to increase the tolerance to severe hypoxia (<0.3% oxygen and high 
temperature) and anoxia (MENDENHALL et al. 2006; SCOTT et al. 2002). This 
hypoxia-tolerant phenotype is suppressed by mutations of daf-16. These data suggest that 
insulin/IGF-1 signaling may function to protect organisms from hypoxic stress in parallel to 
hif-1 pathway. 
Recently, Anderson et al. reported that a reduction-of-function mutation of rrt-1, an 
arginyl-transfer RNA synthetase, produces hypoxia resistance (ANDERSON et al. 2009). The 
mechanisms of this hypoxia-resistance phenotype appear to due to the attenuated translation 
rate, which may decrease the unfolded protein toxicity induced by hypoxia. In addition, using 
genome-wide RNAi screen, the same group identified 198 genes that when knocked down 
increase resistance to severe hypoxia (MABON et al. 2009). Although the normal function of 
these genes seem to increase hypoxia sensitivity, their roles during hypoxia response are not 
clear. 
The connection between hypoxia and aging 
Aging is associated with high incidence of stroke, cancer and ischemia, in which cases 
tissue or cells often experience hypoxia. It is an important question to ask how aging is 
connected to the decreased ability to cope with hypoxia in elderly. As the master regulator of 
transcriptional changes during hypoxia, does HIF play any roles in aging?  
Recent studies suggested that HIF may be functionally involved in aging process. For 
example, it has been shown that hypoxia increased the replicative life span of fibroblasts and 
vascular smooth muscle cells in vitro (MINAMINO et al. 2001; PARRINELLO et al. 2003), 
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which may due to the upregulation of telomerase mediated by HIF-1 (NISHI et al. 2004). On 
the other hand, a reduced protein expression of HIF-1α with increasing age has been found in 
many tissues of mice and rat, including muscle, lung, kidney and brain (FRENKEL-DENKBERG 
et al. 1999; RIVARD et al. 2000; ROHRBACH et al. 2005). The reduced expression of HIF-1α 
in heart tissues from old human and mouse could be correlated with an increased expression 
of PHD3/EGLN3 (ROHRBACH et al. 2005). In addition, comparing the response to hypoxia of 
human young versus old fibroblast cells by microarray analysis demonstrated that many 
genes involved in angiogenesis, including HIF-1 target gene VEGF, was severely reduced in 
old fibroblasts (KIM et al. 2003).  
Despite the emerging correlation between hypoxia and aging, some imperative 
questions remain unanswered. First, is reduced protein expression of HIF-1α a cause or a 
consequence of aging? Second, given that HIF-1 is associated with replicative senescence, 
does HIF-1 influence organismal aging? If the answer is yes, what is the mechanism and how 
does it connect to other signaling pathways that modulate aging? 
THESIS ORGANIZATION 
Hypoxia-inducible factor (HIF-1) transcription factor is the master regulator that 
mediates most of the transcriptional changes during hypoxia adaptation. In this dissertation, I 
studied roles of hif-1 and hypoxia signaling pathway in organismal aging in C. elegans. This 
thesis commences with a general introduction chapter which describes the background 
information related to this study. Chapter 1 starts with an extensive literature review of aging 
study. Major topics include: 1) Cell senescence of mitotic cells as the major contributors to 
human aging; 2) The plasticity of aging in post-mitotic cells in light of neurodegenerative 
diseases; 3) C.elegans as a model system to study post-mitotic aging; 4) Organismal aging 
and lessons learned from long-lived mutant worms. The second part of the review discusses 
the hypoxia response and hypoxia-inducible factor signaling, and their connections to aging 
and aging-related diseases. 
The thesis is then organized into three research manuscripts. Chapter 2 is a copy of a 
paper submitted to PLoS ONE, and describes the role of hif-1 in modulating longevity in 
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C.elegans. In this paper, Yi Zhang generated the hif-1 transgenic animals, performed the life 
span assay and statistic analysis. Zhiyong Shao conducted the gene expression analysis in 
Figure 4C. Zhiwei Zhai contributed to part of the life span analysis of Figure 5D. Chuan 
Shen generated hif-1(ia07) allele, which is used in Figure 5. 
The second paper is a manuscript being prepared for submission. This paper describes 
the extended life span induced by hypoxia in C. elegans and characterizes the roles of hif-1, 
daf-16 and endoplasmic reticulum (ER) stress response signaling in hypoxia mediated 
longevity. Yi Zhang made the primary observation and collected all the data for this 
manuscript. 
The third paper is also a manuscript being prepared for submission. This paper 
describes the role of swan-1, a gene identified through forward genetic screen, in regulating 
HIF-1 activity. Yi Zhang performed the initial characterization of the allele and carried out 
the mapping. Yi Zhang and Zhiyong Shao analyzed the effect of swan-1 on HIF-1 stability 
and HIF-1 target genes.  
The final part of this thesis is a general conclusion chapter that discusses the role of 
HIF-1 and hypoxia signaling pathway in regulating aging, and proposes potential 
experiments for future research. In addition, unpublished data including the 
co-immunoprecipitation experiments in searching for the proteins associated with HIF-1 in 
vivo and some life span assay results are organized in the appendix section. 
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FIGURE LEGEND 
Figure 1. A model of aging modulation in C. elegans.  Aging results from the 
accumulative damages as the consequence of normal metabolism and of unpredictable 
stresses. Environmental and genetic variables modulate aging process through 1) decreasing 
ROS production by adopting alternative bio-energetic metabolism; 2) promoting stress 
resistance by activating key transcription factors; 3) reducing or removing damaged 
macro-molecules by suppressing translation or inducing autophagy.  
 
Figure 2.  Regulation of HIF-1 in C. elegans. The stability of HIF-1 protein is controlled 
by the evolutionarily conserved EGL-9/VHL-1 pathway. Under normoxic conditions, EGL-9 
hydroxylates HIF-1 at Pro-621, which increases the affinity of HIF-1 for VHL-1, a ubiquitin 
E3 ligase. The ubiquitinated HIF-1 is then targeted for degradation by 26S proteasome. 
Hypoxia inhibits the HIF-1 prolyl hydroxylation. Accumulated HIF-1 dimerizes with its 
partner AHA-1 and binds to specific DNA recognition sequences in its target genes to direct 
changes in gene expression. In addition to regulating HIF-1 stability, EGL-9 also inhibits 
HIF-1 transcriptional activity. The molecular mechanism of this pathway is still obscure. 
RHY-1, a multi-pass transmembrane protein inhibits HIF-1 transcriptional activity through 
unknown mechanisms.  
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Figure 1. Mechanisms of aging modulation in C.elegans. 
 
 
 
Figure 2. Regulation of HIF-1 in C.elegans. 
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CHAPTER 2. The HIF-1 hypoxia-inducible factor modulates 
lifespan in C. elegans 
A paper published in PLoS ONE 
Yi Zhang, Zhiyong Shao, Zhiwei Zhai, Chuan Shen and Jo Anne Powell-Coffman 
ABSTRACT 
During normal development or during disease, animal cells experience hypoxic (low 
oxygen) conditions, and the hypoxia-inducible factor (HIF) transcription factors implement 
most of the critical changes in gene expression that enable animals to adapt to this stress. 
Here, we examine the roles of HIF-1 in post-mitotic aging.  We examined the effects of 
hif-1 loss-of-function mutations and of HIF-1 over-expression on longevity in C. elegans, a 
powerful genetic system in which adult somatic cells are post-mitotic. We constructed 
transgenic lines that expressed varying levels of HIF-1 protein and discovered a positive 
correlation between HIF-1 expression levels and longevity.  The data further showed that 
HIF-1 acted in parallel to the SKN-1/ NRF and DAF-16/ FOXO transcription factors to 
promote longevity.  HIF-1 over-expression also conferred increased resistance to heat and 
oxidative stress.  We isolated and characterized additional hif-1 mutations, and we found 
that each of 3 loss-of-function mutations conferred increased longevity in normal lab culture 
conditions, but, unlike HIF-1 over-expression, a hif-1 deletion mutation did not extend the 
lifespan of daf-16 or skn-1 mutants. We conclude that HIF-1 over-expression and hif-1 
loss-of-function mutations promote longevity by different pathways.  These data establish 
HIF-1 as one of the key stress-responsive transcription factors that modulate longevity in C. 
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elegans and advance our understanding of the regulatory networks that link oxygen 
homeostasis and aging.     
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INTRUDUCTION 
During development, homeostasis, and disease, cells integrate diverse environmental 
inputs and implement the appropriate changes in gene expression to survive stresses or 
execute developmental programs.  Of the many environmental challenges that animals 
encounter, oxygen deprivation (hypoxia) is of particular concern. Oxygen is the final electron 
acceptor in cellular respiration, and is, therefore, necessary for metazoan life.  Successful 
adaptation to hypoxia involves changes in genetic programs that modulate metabolism, cell 
death, growth, and cellular differentiation.  Many of these processes also have roles in 
cellular aging.  This suggests that the networks that govern oxygen homeostasis and aging 
may be intertwined, but the molecules and mechanisms that underpin these networks are not 
fully understood. 
 In animals as diverse as humans and C. elegans, the hypoxia-inducible factor (HIF) 
heterodimeric transcription factors are responsible for most of the hypoxia-induced changes 
in gene expression [1,2].  HIFs have been studied intensively by the biomedical research 
community, because HIFs have central roles in cancer and cardiovascular disease.  Small 
molecules that inhibit HIF may be effective chemotherapeutic agents.  Conversely, for 
patients in which injury, anemia, or ischemia has decreased oxygen supply to tissues, 
treatments that increase HIF levels may improve cell survival and stimulate angiogenesis.   
HIF regulatory networks are acutely sensitive to oxygen.  The HIF transcription 
complex is heterodimeric, and both subunits belong to the family of DNA-binding 
transcription factors that include basic-helix-loop-helix and PAS domains.  HIFα stability is 
regulated by oxygen-dependent degradation.  When oxygen levels are sufficiently high, 
HIFα is hydroxylated by the members of the EGL-9 / PHD family of Fe(II)- and 
2-oxoglutarate-dependent dioxygenases. This modification allows VHL, a ubiquitin E3 ligase, 
to bind HIFα and target it for proteasomal degradation.  In hypoxic conditions, HIFα is 
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stable, and the HIF complex activates a battery of genes that enable adaptation to low oxygen 
conditions.  HIF stability and activity are influenced by reactive oxygen species, citric acid 
cycle intermediates, Fe(II) availability, and intracellular signaling events [1,3].  HIFs are, 
therefore, well-positioned to integrate information about oxygen availability and cellular 
redox and to effect changes that influence stress resistance.  
Here, we test the hypothesis that HIF modulates post-mitotic aging.  Previous studies in 
human cells had demonstrated that HIF promoted telomerase expression [4] and that this 
contributed to increases in the replicative lifespan of primary human lung fibroblasts in 
hypoxic conditions [5], but the roles of HIF in post-mitotic aging were not understood.  The 
somatic cells of an adult C. elegans are post-mitotic, and the rate of aging can be modulated 
by genes that control insulin receptor signaling, mitochondrial function, protein folding, or 
response to reactive oxygen species and other stresses [6,7].  The C. elegans genome 
encodes a single HIF alpha subunit, HIF-1, and mutants lacking a functional hif-1 gene are 
viable in normal culture conditions [8,9]. In this study, we report that over-expression of 
HIF-1 protein extends the lifespan of C. elegans in a dose-dependent manner.  Interestingly, 
we find that loss-of-function mutations in hif-1 gene can also increase C. elegans longevity 
and stress tolerance.  The HIF-1 over-expression and hif-1 loss-of-function longevity 
phenotypes are not equivalent, as they differ in their dependence on daf-16/FOXO and 
skn-1/NRF2.  These data provide insights to the intersection between oxygen homeostasis 
and aging, and they suggest that post-mitotic aging may be influenced by treatments or 
mutations that alter HIF-1 signaling.  
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RESULTS 
HIF-1 over-expression causes dose-dependent extension of adult 
lifespan.   
A small group of transcriptional regulators lying in the core of the stress response 
network, including DAF-16, SKN-1, SIR-2.1, PHA-4 and HSF-1, had been shown to extend 
lifespan when activated or over-expressed in transgenic C. elegans [10,11,12,13,14,15,16].  
To determine whether HIF-1 had similar effects, we generated a series of transgenic animals 
with extra copies of hif-1 integrated into the genome.  The hif-1 minigene is a fusion of 
genomic and cDNA sequences, and it includes a c-myc tag (Fig 1A).  We confirmed that the 
epitope-tagged HIF-1 protein, like endogenous HIF-1, was over-expressed in animals that 
lacked vhl-1 or egl-9 (Fig 1B).  Further, the transgene was able to restore expression of a 
HIF-1-dependent reporter, Pnhr-57:GFP, to a hif-1 deletion mutant (Fig 1C).  In two 
independent lines (iaIs27 and iaIs28), the hif-1 integrated transgenes conferred moderate 
lifespan extension (22 or 23 days, p<0.0001, Tables 1 and S1). 
To further test the hypothesis that HIF-1 over-expression increased lifespan in C. 
elegans, we constructed a transgene in which HIF-1 proline 621 was converted to glycine.  
In wild-type animals, HIF-1 proline 621 is hydroxylated by EGL-9, and this covalent 
modification had been shown to mediate binding of HIF-1 to VHL-1 [17].  Mutations in 
vhl-1 or egl-9 can also be used to inhibit HIF-1 degradation, but these mutations have other 
defects that can complicate interpretation of the phenotypes.  The vhl-1(ok161) deletion 
causes some changes in extracellular matrices that are not suppressed by a mutation in hif-1 
[18], and animals carrying strong loss-of-function mutations in egl-9 have an array of 
morphological and behavioral defects [19,20].  To understand the effects of HIF-1 
over-expression, we generated transgenic animals carrying the hif-1 (P621G) expression 
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construct and analyzed 3 independently isolated lines (iaIs32, iaIs33, and iaIs34).  As 
shown in Fig. 1D, the HIF-1(P621G) gain-of-function mutation released the protein from 
degradation via the egl-9/vhl-1 pathway. In these strains, the HIF-1 (P621G) protein was 
expressed at levels 3 – 14 times greater than HIF-1 expressed from transgenes without the 
stabilizing mutation (Fig 2A).  The hif-1 (P621G) lines lived 20% - 34% longer than 
wild-type N2 worms (Fig. 2B, Table 1).  Moreover, the mean adult lifespans of the five 
hif-1 transgenic strains were proportionately correlated with HIF-1 expression levels (Fig. 
2C).  These data established that HIF-1 over-expression caused dose-dependant lifespan 
extension.  
 
HIF-1 over-expression acts in parallel to DAF-16 and SKN-1 to extend 
lifespan.   
Mutations in the daf-2 insulin-like receptor gene increase nuclear localization of the 
DAF-16 FOXO transcription factor and dramatically increase longevity and resistance to 
heat or oxidative stress.  Conversely, daf-16 loss-of-function mutants age quickly 
[10,13,21,22,23,24].  We considered the possibility that loss-of-function mutations in daf-16 
might be epistatic to HIF-1 over-expression in longevity assays.  As shown in Fig. 3A and 
Table 2, hif-1(P621G) transgenes increased the mean lifespan of daf-16 (mu86) mutants by 
up to 33%.  This was very similar to the effect that HIF-1(P621G) had on wild-type animals 
(Table 1).  This indicates that HIF-1 and DAF-16 were acting in parallel to influence 
post-mitotic aging.   
SKN-1 is a transcription factor that mediates the phase II detoxification response during 
oxidative stress in C. elegans [25], and expression of constitutively active SKN-1 can extend 
lifespan via genetic pathways that are independent of DAF-16 [15].  We tested the 
hypothesis that a loss-of-function mutation in skn-1 could abolish the prolongevity effects of 
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HIF-1 over-expression.  As shown in Fig 3B and Table 2, over-expression of HIF-1 through 
hif-1(P621G) transgenes extended the lifespan of skn-1(zu67) mutants by up to 25%.  
We then asked whether the longevity effect of increased HIF-1 protein was independent 
of the DAF-2 insulin-like signaling pathway by crossing the hif-1(P621G) transgene to a 
long-lived daf-2 loss-of-function mutant.  The hif-1 (P621G) transgene did not extend the 
lifespan of daf-2(e1370) worms (Fig. 3C, Table 2).  Taken together, the genetic data 
indicate that increased dosage of HIF-1 promotes longevity via a pathway that acts in parallel 
to DAF-16 and SKN-1, but may be downstream of the DAF-2 insulin-like receptor.   
Studies in mammalian cell lines have shown that the insulin receptor pathway can 
influence translation of HIF-1α, and recent studies in C. elegans have suggested that DAF-16 
might regulate HIF-1 expression in some developmental or environmental contexts [26,27].  
To directly test the hypothesis that DAF-2 regulated total HIF-1 protein levels, we compared 
the expression of epitope-tagged HIF-1 in wild-type animals and in daf-2 (e1370) mutants.  
We also assayed the expression of two HIF-1 targets: Pnhr-57:GFP and K10H10.2. Prior 
studies had shown that K10H10.2 mRNA levels were induced by hypoxia in wild-type 
animals in a hif-1-dependent manner and that mutations that caused over-expression of HIF-1 
protein resulted in over-expression of K10H10.2 mRNA [2,20].  As shown in Fig 4A, the 
daf-2 (e1370) mutation did not have a significant effect on the expression levels of HIF-1 or 
HIF-1(P621G) proteins (Fig 4A) or on the expression of two HIF-1 targets that we assayed 
(Figs. 4B, 4C).  
 
Effects of hif-1 loss-of-function mutations on longevity.   
Prior studies did not clearly predict the effects a hif-1 loss-of-function mutation might 
have on longevity.  HIF-1 had been shown to promote the expression of genes that inhibit 
formation of stress resistant dauer larvae.  In accordance with this, hif-1 (ia04) mutants 
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arrest larval development as partial dauers when cultured at 27oC [2].  Since mutations that 
confer stress resistance and dauer formation are often correlated with longer lifespan, it was 
reasonable to expect that hif-1 mutants might age slowly.  However, loss-of-function 
mutations in the daf-16 or skn-1 prolongevity genes are associated with premature aging 
[22,24,25], and our data in Fig. 2 had established that over-expression of HIF-1 extended 
lifespan.  To address this question directly, we assayed the lifespans of wild-type animals 
and hif-1 (ia04) mutants.  Under normal culture conditions (20oC), hif-1 (ia04) mutants 
lived approximately 20% longer than wild-type animals (24 days, compared to 20 days for 
wild-type N2) (Table 1).  To further validate this finding, we isolated an additional 
loss-of-function allele in hif-1 [hif-1 (ia07), described in Figs 5A and 5B].  Sequence 
analysis predicts that hif-1 (ia07) should encode a truncated protein lacking a transcriptional 
activation domain.  We also characterized hif-1 (ok2564), a deletion allele isolated by the C. 
elegans Genome Consortium (Figs 5A).  Phenotypic analyses confirm that both hif-1 (ia07) 
and hif-1 (ok2564) decrease expression of HIF-1 targets (Fig 5C). Each of the hif-1 
loss-of-function alleles increased the mean adult lifespan by at least 10% (Fig 5D, Table 1).  
hif-1 RNAi also extended the lifespan of wild-type animals (Table S2). 
To understand whether the longevity phenotypes conferred by HIF-1 over-expression 
and hif-1 loss-of-function mutations had similar genetic underpinnings, we asked whether the 
hif-1(ia04) mutation could extend the lifespan of daf-16- or skn-1-deficient mutants.  As 
illustrated in Fig 5E and 5F, daf-16 (mu86) animals and daf-16 (mu86) hif-1 (ia04) double 
mutants had similarly short lifespans (~15 days), and there was not a significant difference 
between daf-2(e1370) and daf-2(e1370) hif-1(ia04) animals.  We also determined that the 
hif-1 (ia04) deletion mutation did not extend the lifespan of skn-1(zu67) animals (Fig 5G, 
Table 2).  These data suggest that hif-1 loss-of-function mutations extend life span via a 
mechanism that requires daf-16 and skn-1 function.  Thus, the longevity phenotypes of 
HIF-1 over-expressing animals and hif-1 (ia04) animals can be distinguished by their 
requirements for daf-16 and skn-1 function.   
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Resistance to t-butyl-peroxide and heat stress.   
Thermotolerance and stress resistance have been shown to be correlated with C. elegans 
longevity [28,29].  To determine whether changes in hif-1 dosage that extend lifespan also 
conferred resistance to oxidative stress, we assessed relative resistance to t-butyl-peroxide.  
We assayed two loss-of-function alleles of hif-1 and two lines that expressed the stabilized 
HIF-1 (P621G).  All of these strains exhibited significantly higher rates of survival in the 
oxidizing agent compared to wild-type (Fig. 6A).  We also tested the ability of these strains 
to withstand heat stress.  Prior studies had determined that both hif-1 (ia04) mutants and 
egl-9-deficient mutants were more resistant to heat stress than were wild-type animals [30].  
We extended these studies and determined that, similar to the findings in peroxide treatment, 
loss-of-function mutations in hif-1 or over-expression of HIF-1 increased the ability of the 
animals to survive at 35ºC (Fig. 6B).  
 
DISCUSSION 
This study advances our understanding of the regulatory networks that link oxygen 
homeostasis and aging. Cells respond to oxygen deprivation by changing their patterns of 
gene expression to optimize energy production and mitigate cellular damage. Oxygen 
deprivation can extend the replicative lifespan of cells in culture [5], and C. elegans cultured 
in hypoxic conditions live longer .  The hypoxia-inducible factors have been termed master 
regulators of oxygen homeostasis , and in C. elegans, HIF-1 is required for most of 
hypoxia-induced changes in gene expression [2].  Genes regulated by HIF-1 include genes 
involved in metabolism, cell signaling, transcription and translation.  We show here that 
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over-expression of HIF-1 extends C. elegans lifespan in a dose-dependent manner.  We 
hypothesize that multiple HIF-1 targets act in concert to slow cellular deterioration over time. 
Effects of HIF-1 over-expression 
When over-expressed, HIF-1 acts in parallel to the stress responsive transcription factors 
DAF-16 / FOXO and SKN-1 / NRF to promote longevity.  In wild-type animals, DAF-16 
and SKN-1 are inhibited by the sole C. elegans insulin-like growth factor receptor, DAF-2.  
Analogous to mammalian IGF signaling pathways, DAF-2 regulates phosphoinositide 
3-kinase (PI3K) signaling.  The effectors of PI3K include kinases (AKT-1, AKT-2, and 
SGK-1) that phosphorylate DAF-16 and SKN-1 to repress transcription factor nuclear 
localization [15,33,34].  As illustrated in Fig 3, HIF-1 over-expression can extend the 
lifespan of daf-16 or skn-1 loss-of-function mutants.  Microarray studies have suggested 
that HIF-1 and DAF-16 may co-regulate some genes, but HIF-1 and DAF-16 clearly have 
independent functions as well [2,35].  The relationship between HIF-1 and DAF-2 is less 
clear.  The genetic data leave open the possibility that the prolongevity functions of HIF-1 
are regulated by DAF-2. DAF-2 and the PI3K pathway have been shown to have other 
DAF-16-independent functions, including regulation of SKN-1 nuclear localization [15]. 
Additionally, mutations in daf-2 were shown to confer resistance to some hypoxia-induced 
defects in neural development [27].  Here, we have demonstrated that mutations in daf-2 did 
not cause significant changes in whole animal levels of HIF-1 protein or in the expression of 
two HIF-1 targets that we assayed (Fig 4), but DAF-2 may have tissue-specific or 
stage-specific roles in HIF-1 regulation.  
A recent independent study from the Kaeberlein research group provides added support 
for the conclusion that HIF-1 over-expression extends C. elegans lifespan.  Mehta et al 
reported that vhl-1 or egl-9 RNAi increased C. elegans longevity and decreased the toxic 
effects of transgenes that expressed polyglutamine repeats or beta amyloid.  Further, they 
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showed that daf-16 RNAi did not completely suppress the longevity conferred by a vhl-1 
deletion mutation, and they found that vhl-1 RNAi had no effect on the nuclear localization 
of DAF-16:GFP .   
While moderate increases in HIF-1 protein expression promote longevity, dramatic 
over-expression of HIF-1 target genes can be detrimental.  Dramatic over-expression of 
HIF-1 target genes in C. elegans egl-9 mutants is associated with a range of morphological 
and behavioral defects [19,20,37].  We and others have shown that animals carrying a 
strong loss-of-function mutation in egl-9 do not live longer than wild-type animals (Table 1 
and ).  This suggests animals treated with egl-9 RNAi or animals carrying transgenes 
expressing stabilized HIF-1 benefit from increased HIF-1 function, but only to a point.  
Forcing gene expression beyond normal parameters can be deleterious.  A similar pattern 
has been reported for yeast LAG1 and for C. elegans SKN-1.  Moderate over-expression of 
SKN-1 extends life span, but over-expression from high copy transgenes is toxic [15].   
 
Effects of hif-1 loss-of-function 
hif-1 loss-of-function mutations and hif-1 RNAi can also extend lifespan, but HIF-1 
over-expression and hif-1 loss-of-function mutations exert their prolongevity effects through 
different pathways.  We demonstrated that three independently isolated hif-1 mutations 
extended C. elegans lifespan. The hif-1 (ia07) allele is predicted to encode a truncated HIF-1 
protein that lacks a transcriptional activation domain, and the hif-1(ia07) phenotype is 
slightly more severe than the phenotypes of the hif-1 (ia04) and hif-1 (ok2564) deletion 
alleles (Fig 5A).  In agreement with our findings, the Kapahi group determined that hif-1 
RNAi increased C. elegans lifespan, and they demonstrated that this effect was abrogated by 
dietary restriction .  These data shown that the hif-1 loss-of-function phenotype can be 
strongly influenced by the bacterial food.  
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There are also some intriguing differences between our findings and those from the other 
two groups that have recently examined the roles of HIF-1 in C. elegans aging.  While we 
report and Chen et al  have reported that hif-1-deficient animals live longer when food is 
abundant, Mehta et al  did not detect differences between the lifespans of hif-1 (ia04) and 
wild-type animals in their experiments.  This appears to reflect differences in assay 
conditions. Small differences in the bacterial food source, the temperature, or other 
conditions may alter the longevity phenotypes of hif-1-deficient animals. Chen et al 
conducted their experiments at 25oC, and they assayed the effects of varying amounts of live 
bacterial food on plates containing FUdR and antibiotics .  Mehta et al performed their 
experiments at 20oC and fed the animals UV-treated bacteria on plates containing FUdR and 
antibiotics . All of the longevity assays that we report here were conducted in nutrient rich 
conditions in the absence of DNA synthesis inhibitors.  Although our findings regarding the 
hif-1 loss-of-function phenotype largely agree with those of Chen et al, there are open 
questions about the role of daf-16 in hif-1-deficient animals. Chen et al found that hif-1 RNAi 
could extend the mean lifespan of daf-16 (mgDf47) animals by 18%.   In our experiments, 
double mutants carrying loss-of-function mutations in both hif-1 and daf-16 had similar 
lifespans to daf-16 (mu86) single mutants (Fig 3).  
 
HIF-1 and hormesis 
 Why might apparently small differences in assay conditions influence the 
phenotypes of hif-1-deficient animals?  The answer to this question may require a fuller 
understanding of the roles of HIF-1 in heat acclimation and hormesis. Wild-type C. elegans 
that have been incubated at 25oC are more thermotolerant than animals that have been 
incubated at 20oC.  This process of requires hif-1 function [30].  These data, when 
considered with the findings presented here, suggest that while loss-of-function mutations in 
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hif-1 or HIF-1 over-expression can increase thermal resistance (Fig 6 and [30]), 
hif-1-deficient animals are less able to adapt to or benefit from changes in the environment.  
C. elegans have been shown to be more sensitive to oxygen deprivation at high temperatures 
[40,41].  Future studies will investigate the ways in which culture conditions and 
environmental stresses can influence HIF-1 function and hif-1-deficient phenotypes and may 
discover additional roles for HIF-1 in aging, stress, and hormesis. 
 
Selective pressures to control HIF-1 signaling 
To our knowledge, this is the first case in a multicellular organism in which wild-type 
animals (grown in nutrient-rich conditions) have been shown to live shorter than either 
loss-of-function mutants or animals over-expressing the protein.  However, in yeast, both 
loss-of-function mutations in the LAG1 longevity assurance gene and moderate 
over-expression of LAG1 can extend replicative lifespan .  Recent studies in mammalian 
cells have shown that similar phenotypes can be caused by loss-of-function or 
gain-of-function mutations that force a signaling pathway outside of its normal range.  For 
example, in models for TNF-induced apoptosis, kinase-dead and constitutively active MK2 
mutants have been shown to have similar effects on apoptosis .  When considering the 
complex roles of HIF-1 in aging, it is important to recognize that HIF-1 over-expression and 
hif-1 loss-of-function phenotypes are qualitatively different and have distinct genetic 
requirements.   
In the hundreds of millions of years since nematodes and mammals diverged from a 
common ancestor, some of the key molecules and feedback loops that modulated HIF 
signaling have been conserved [17,43].  The EGL-9 / VHL-1 pathway enables rapid 
up-regulation of HIF in hypoxic conditions, but the system is tightly controlled.  In humans 
and in C. elegans, activation of HIF results in increased expression of the HIF prolyl 
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hydroxylases (PHD / EGL-9) [2,18].  This establishes a negative feedback loop to attenuate 
HIF expression. While either hif-1 depletion or HIF-1 over-expression increase longevity in 
optimal lab culture conditions, the conservation of HIF regulatory networks suggests that 
there is a strong selective pressure for keeping HIF signaling within a normal range, where 
HIF can effectively respond to subtle changes in the environment. 
Small molecule inhibitors of the HIF prolyl hydroxylases are being developed as 
treatments for anemia or other pathologies that may be ameliorated by increased HIF 
expression.  There is also great interest in pharmaceuticals that can inhibit HIF and may be 
effective in combinatorial treatments for certain cancers .  We anticipate that drugs that 
target HIF may have widespread, dose-dependent impacts on stress resistance and on somatic 
aging.   
 
MATERIALS AND METHODS 
C. elegans strains 
The mutant alleles were as follows: LGI: daf-16(mu86)lf; LGII: daf-2(e1370) 
reduction-of-function; LGV: hif-1(ia04)lf, hif-1(ia07)lf, hif-1(ok2564)lf, egl-9(sa307)lf; LGX: 
vhl-1(ok161)lf.   
 
hif-1 minigenes and generation of transgenic animals 
The pFOX1 and pFOX4 constructs encode wild-type HIF-1 and HIF-1(P621G), 
respectively. pFOX1 includes 5.2 kb genomic sequence 5’ to the hif-1 coding region.  The 
first exon and first intron of hif-1 are fused to a cDNA fragment including exon 2 to exon 9 
of hif-1 (for the predominant mRNA isoform: hif-1a).  Five copies of c-myc epitope (5×myc) 
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(from clone CD3-128, Arabidopsis Biology Resources Center) were inserted C-terminal to 
hif-1 coding sequences, and this was followed by a stop codon and 400 bp of genomic 
sequence just 3’ to the hif-1 coding region. To create pFOX4, the P621G point mutation was 
introduced to the pFOX1 sequence.  Microparticle bombardment was used create C. elegans 
carrying integrated copies of each construct.  The hif-1 constructs were introduced to hif-1 
(ia04), unc-119(ed3) animals, and the unc-119 rescuing plasmid pPD#MM016b was the 
co-transformation marker .  Animals carrying integrated copies of the transgenes were 
isolated and backcrossed at least four times prior to further characterization. 
 
Lifespan and stress analyses 
Longevity assays were conducted as described previously  unless noted otherwise.  
Prior to life span assays, all strains were maintained at 20oC for at least two generations with 
abundant food.  The OP50 bacterial food was grown in L-broth to a 600 nm optical density 
of approximately 0.4, and 250 microliters of live bacterial culture was spotted onto each 60 
mm NGM plate.  The plates did not contain FUdR or antibiotics.  One to three days later, 
young adult hermaphrodites were allowed to lay eggs overnight on the bacterial food.  The 
L4 larvae grown from these eggs were transferred to fresh plates.  Each plate included 20 – 
25 animals, and at least 50 animals were used in each independent trial.  The worms were 
transferred to new plates every two days for the first two weeks and every six days thereafter.  
The data from individual experiments are listed in Table S1.  Any experiments in which the 
assay conditions were modified are explicitly noted in the text and in the legends for Tables 
S2 and S3.  Viability was scored every 2 days.  Worms that crawled off the plates, burst at 
the vulva or died because progeny hatched in utero were excluded from final statistical 
analyses. Life span statistical analyses were carried out using JMP software (version 7.0) to 
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determine the means and percentiles. p values were calculated using the log-rank 
(Mantel-Cox) method.  
 In oxidative stress assays, young adult worms (one day after L4 molt) were 
transferred to NGM plates containing 7.2 mM t-butyl-peroxide (Sigma) and OP50 food. 
Animals were incubated at 20ºC and were scored for survival at the time points shown. For 
thermal stress assays, young adult worms were incubated at 35ºC on NGM plates seeded with 
OP50 and were scored for survival. At least 50 worms were tested in each trial and at least 
three independent trials were performed for each stress assay. 
Protein blots and Quantitative RT-PCR 
For each lane of an immunoblot, ten (for Pnhr57:GFP) to 100 (for the epitope-tagged 
HIF-1) L4 or young adult worms were assayed. Mouse anti-AHA-1 antibody (cell culture 
supernatant)  was produced in ISU Hybridoma Facility and used at 1:100. Mouse anti-myc 
ascites (clone 9E10) from the Developmental Studies Hybridoma Bank was used at 1:1000. 
Mouse anti-GFP antibody (from Roche) was used at 1:1000. 
Quantitative RT-PCR was performed as described previously [20]. inf-1 is not regulated 
by hypoxia and was used as an input control. The standard curve method was used to analyze 
the expression levels.  Student t-tests were used to determine the p value for protein 
expression and quantitative RT-PCR data. 
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FIGURE LEGENDS 
Figure 1.  Characterization of the hif-1 and hif-1(P621G) transgenes. (A) Diagram of 
the minigenes that express epitope-tagged HIF-1. Genomic sequence including the hif-1 
promoter sequence, exon 1, and intron 1, was fused to cDNA including exons 2- 9 for the 
predominant hif-1 mRNA isoform (hif-1a).  A myc epitope tag was inserted.  A proline to 
glycine conversion at amino acid residue 621 prevents VHL-1-mediated degradation [17]. (B) 
Representative protein blots show that epitope-tagged HIF-1 is stabilized by loss-of-function 
mutations in vhl-1 or egl-9.  (C) Western blots show the transgene restores HIF-1-mediated 
gene expression.  Pnhr-57:GFP is a reporter for HIF-1 activity [20].  Its expression is 
dramatically reduced in hif-1(ia04) mutants and is restored by the iaIs28 integrated hif-1 
transgene. (D) Oxygen-dependent degradation via the vhl-1 / egl-9 pathway is abolished 
when the HIF-1 proline residue 621 is mutated to glycine. 
 
Figure 2. HIF-1 over-expression extends longevity in a dose-dependent manner. (A) 
Protein blots quantitate expression of HIF-1 and HIF-1(P621G) transgenes (tagged with the 
myc epitope). iaIs27 and iaIs28 contain integrated copies of the hif-1 minigene.  iaIs32, 
iaIs33, and iaIs34 carry integrated copies of hif-1 (P621G).  AHA-1 is ortholgous to HIFβ / 
ARNT [46], and the abundance of AHA-1 does not vary significantly in these strains. (B) 
Strains carrying hif-1 transgenes live longer (p<0.0001).  Proportion alive is plotted over 
time. (C)  The mean adult lifespans of strains over-expressing HIF-1 are positively 
correlated with the HIF-1 expression levels.  Error bars represent the standard errors of the 
means. 
 
Figure 3.  HIF-1 over-expression extends the lifespan of daf-16-deficient and 
skn-1-deficient mutants. (A, B) hif-1(P621G) transgenes (iaIs32 or iaIs34) extend the 
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lifespan of animals carrying loss-of-function mutations in (A) daf-16 (p<0.0001) or (B) skn-1 
(p<0.0001).  (C) The longevity of daf-2(e1370) animals carrying a hif-1 (P621G) transgene 
is equivalent to that of daf-2(e1370) single mutants at 25οC.  
 
Figure 4.  The daf-2 insulin-like receptor does not regulate expression of HIF-1 protein 
or its targets. (A) A reduction of function mutation in daf-2 does not change the protein 
levels of epitope-tagged HIF-1 (iaIs28) or HIF-1(P621G) (iaIs32) in young adult animals 
(p>0.2 from three independent experiments). (B,C) The expression of two HIF-1 targets were 
assayed in wild-type animals and in animals carrying a loss-of-function mutation in daf-2.  
(B) Pnhr-57:GFP expression was assayed by protein blots and was not significantly different 
in these genetic backgrounds (p>0.2 from three independent experiments) (B) Quantitative 
RT-PCR revealed a marginal differences in the levels of K10H10.2 mRNA (p = 0.09).  
 
Figure 5.  hif-1 loss-of-function mutations extend the lifespan of wild-type animals, via 
pathway(s) that require daf-16 and skn-1. (A,B) Characterization of hif-1 mutation alleles.  
(A) The hif-1 locus encodes 4 mRNA isoforms (www.wormbase.org). Exons are depicted as 
boxes, with coding sequences in black and untranslated regions in grey. The positions of two 
deletion alleles (ia04 and ok2564) and one nonsense mutation (ia07) are shown. (B) The 
hif-1 (ia07) point mutation introduces an early stop codon;  (C) Protein blots show that all 
three mutations in hif-1 repress expression of the Pnhr-57::GFP reporter [20].  Expression 
was assayed in vhl-1 (ok161) mutants, which are defective in oxygen-dependent degradation 
of HIF-1.  (D) C. elegans carrying hif-1 loss-of-function mutations live longer than 
wild-type N2 (p<0.0001). (E) hif-1(ia04);daf-16(mu86) double mutant animals do not live 
longer than daf-16(mu86) single mutants. (F) daf-2 (e1370) single mutants and daf-2 (e1370); 
hif-1(ia04) double mutants have equivalent lifespans at 25οC. (G) hif-1(ia04);skn-1(zu67) 
double mutant animals do not live longer than skn-1(zu67) single mutants.  
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Figure 6.  hif-1 loss-of-function mutations and HIF-1 over-expression increase 
oxidative stress resistance and thermotolerance.  (A, B) Resistance to (A) t-butyl 
peroxide or (B) heat stress was assayed in hif-1 loss-of-function mutants and in animals 
over-expressing HIF-1.  The daf-2 (e1370) and daf-16 (mu86) strains were included as a 
basis for comparison. Error bars represent the standard error of the means from at least 3 
experiments. (*, p<0.0001 compared to wild type N2 worms using z-test). 
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Table 1. Over-expression of HIF-1 protein or hif-1 loss-of-function mutations extend the 
adult lifespan in C. elegans in standard lab culture conditions. 
strain 
life span 
mean +S.E. 
Percentage 
v. N2 n p value* 
number 
of exp 
N2 wild-type 20.0 ± 0.3  166  4 
iaIs27 [Phif-1::hif-1::myc] 22.3 ± 0.4 12 109 <0.0001 3 
iaIs28 [Phif-1::hif-1::myc] 23.0 ± 0.3 15 131 <0.0001 3 
iaIs32 [Phif-1::hif-1(P621G)::myc] 25.9 ± 0.6 30 117 <0.0001 3 
iaIs33 [Phif-1::hif-1(P621G)::myc] 24.1 ± 0.5 20 125 <0.0001 3 
iaIs34 [Phif-1::hif-1(P621G)::myc] 26.7 ± 0.4 33 125 <0.0001 3 
hif-1(ia04) 24.1 ± 0.5 20 147 <0.0001 4 
hif-1(ia07) 27.0 ± 0.6 35 56 <0.0001 2 
hif-1(ok2564) 22.4 ± 0.6 12 74 <0.0001 2 
egl-9(sa307) 20.8 ± 0.3 4 126 0.2 4 
egl-9(sa307);hif-1(ia04) 19.2 ± 0.3 -4 134 0.3 3 
 
* The longevity of each strain was compared to wild-type, and the p values were calculated 
by log-rank tests. 
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Table 2. Effects of HIF-1 over-expression or hif-1 loss-of-function mutations on the 
longevity of daf-16 or skn-1 mutants. 
strain 
Adult life span 
mean +S.E. 
Percentage 
v. control n p value 
number of 
exp 
daf-16(mu86) 15.1 ± 0.2  191  5 
daf-16(mu86); hif-1(ia04) 14.8 ± 0.3 -2 105 0.3* 3 
daf-16(mu86); iaIs32 19.0 ± 0.4 27 77 <0.0001* 2 
daf-16(mu86); iaIs34 20.2 ± 0.4 33 78 <0.0001* 2 
skn-1(zu67) 15.4 ± 0.3  87  2 
skn-1(zu67);hif-1(ia04) 14.8 ± 0.4 -4 76 0.5† 2 
skn-1(zu67); iaIs32 19.2 ± 0.4 25 98 <0.0001† 2 
skn-1(zu67); iaIs34 17.6 ± 0.4 14 108 <0.0001† 2 
daf-2(e1370) 32.5 +1.1  76  3 
daf-2(e1370); hif-1(ia04) 34.0 +1.2 5 75 0.2‡ 3 
daf-2(e1370); iaIs32 29.2 +1.8 -10 45 0.9‡ 3 
daf-2(e1370); iaIs34 30.2 +1.2 -7 65 0.9‡ 3 
 
* The p value was calculated by log-rank test as a comparison to daf-16(mu86) worms. 
† The p value was calculated by log-rank test as a comparison to skn-1(zu67) worms. 
‡The p value was calculated by log-rank test as a comparison to daf-2(e1370) worms. 
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Figure 1. Characterization of the hif-1 and hif-1(P621G) transgenes. 
 
 
 
 
Figure 2. HIF-1 over-expression extends longevity in a dose-dependent manner. 
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Figure 3. HIF-1 over-expression extends the lifespan of daf-16-deficient and skn-1-deficient 
mutants. 
 
 
Figure 4. The daf-2 insulin-like receptor does not regulate expression of HIF-1 protein or its 
targets. 
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Figure 5. hif-1 loss-of-function mutations extend the lifespan of wild-type animals, via 
pathway(s) that require daf-16 and skn-1. 
 
 
 
Figure 6. hif-1 loss-of-function mutations and HIF-1 over-expression increase oxidative 
stress resistance and thermotolerance.   
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SUPPLEMENTAL INFORMATION 
Table S1: Data from individual lifespan experiments 
Genotype 
life span 
mean +S.E. 
Percentage v. 
control 
Maximum 
lifespan n p value* 
N2 wild-type 19.9 ± 0.5  26 41  
N2 wild-type 20.3 ± 0.6  26 39  
N2 wild-type 20.0 ± 0.6  26 41  
N2 wild-type 20.4 ± 0.5  30 45  
iaIs27 [Phif-1::hif-1::myc] 23.5 ± 0.5 18* 34 47 <0.0001* 
iaIs27 [Phif-1::hif-1::myc] 21.3 ± 0.8 7* 36 45 0.04* 
iaIs27 [Phif-1::hif-1::myc] 21.4 ± 1.2 7* 36 17 0.03* 
iaIs28 [Phif-1::hif-1::myc] 24.6 ± 0.6 23* 36 46 <0.0001* 
iaIs28 [Phif-1::hif-1::myc] 22.0 ± 0.6 10* 28 40 0.003* 
iaIs28 [Phif-1::hif-1::myc] 22.2 ± 0.4 11* 30 45 0.001* 
iaIs32 [Phif-1::hif-1(P621G)::myc] 27.2 ± 0.7 36* 36 41 <0.0001* 
iaIs32 [Phif-1::hif-1(P621G)::myc] 27.0 ± 1.1 35* 38 39 <0.0001* 
iaIs32 [Phif-1::hif-1(P621G)::myc] 23.4 ± 0.9 17* 36 37 <0.0001* 
iaIs33 [Phif-1::hif-1(P621G)::myc] 25.3 ± 0.8 27* 36 42 <0.0001* 
iaIs33 [Phif-1::hif-1(P621G)::myc] 24.7 ± 1.2 23* 40 41 <0.0001* 
iaIs33 [Phif-1::hif-1(P621G)::myc] 22.2 ± 0.7 11* 34 42 0.001* 
iaIs34 [Phif-1::hif-1(P621G)::myc] 28.3 ± 0.6 42* 38 36 <0.0001* 
iaIs34 [Phif-1::hif-1(P621G)::myc] 27.3 ± 0.8 37* 38 43 <0.0001* 
iaIs34 [Phif-1::hif-1(P621G)::myc] 24.9 ± 0.5 25* 34 46 <0.0001* 
hif-1(ia04) 25.7 ± 1.1 34* 34 27 <0.0001* 
hif-1(ia04) 24.2 ± 0.7 21* 34 43 <0.0001* 
hif-1(ia04) 25.6 ± 0.8 28* 32 44 <0.0001* 
hif-1(ia04) 21.5 ± 0.7 8* 32 33 0.002* 
hif-1(ia07) 26.6 ± 1.0 33* 36 29 <0.0001* 
hif-1(ia07) 27.2 ± 0.9 36* 38 33 <0.0001* 
hif-1(ok2564) 22.8 ± 0.6 14* 30 43 <0.0001* 
hif-1(ok2564) 22.2 ± 0.7 11* 31 31 <0.0001* 
egl-9(sa307) 21.8 ± 0.7 9* 29 32 0.007* 
egl-9(sa307) 21.5 ± 0.5 8* 26 27 0.007* 
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egl-9(sa307) 20.5 ± 0.7 3* 30 34 0.45* 
egl-9(sa307) 19.6 ± 0.6 -2* 28 38 0.41* 
egl-9(sa307);hif-1(ia04) 18.7 ± 0.5 -7* 24 45 0.3* 
egl-9(sa307);hif-1(ia04) 20.7 ± 0.4 4* 26 47 0.8* 
egl-9(sa307);hif-1(ia04) 18.1 ± 0.4 -9* 26 42 0.0003* 
daf-16(mu86) 15.6 ± 0.6  22 41  
daf-16(mu86) 15.4 ± 0.5  20 37  
daf-16(mu86) 15.1 ± 0.6  24 34  
daf-16(mu86) 15.2 ± 0.4  20 40  
daf-16(mu86) 14.1 ± 0.4  20 39  
daf-16(mu86); hif-1(ia04) 13.7 ± 0.4 -12† 20 41 0.003† 
daf-16(mu86); hif-1(ia04) 14.5 ± 0.4 -6† 20 33 0.14† 
daf-16(mu86); hif-1(ia04) 16.6 ± 0.4 10† 20 30 0.11† 
daf-16(mu86); iaIs32 19.8 ± 0.6 30† 26 41 <0.0001† 
daf-16(mu86); iaIs32 18.1 ± 0.7 28† 26 36 <0.0001† 
daf-16(mu86); iaIs34 20.3 ± 0.6 33† 28 40 <0.0001† 
daf-16(mu86); iaIs34 20.2 ± 0.6 33† 26 38 <0.0001† 
skn-1(zu67) 15.1 ± 0.3  22 58  
skn-1(zu67) 16.1 ± 0.7  26 29  
skn-1(zu67);hif-1(ia04) 14.6 ± 0.4 -3‡ 20 52 0.57‡ 
skn-1(zu67);hif-1(ia04) 15.5 ± 1.1 -4‡ 30 24 0.8‡ 
skn-1(zu67); iaIs32 19.1 ± 0.5 26‡ 28 58 <0.0001‡ 
skn-1(zu67); iaIs32 19.4 ± 0.7 20‡ 30 40 <0.0001‡ 
skn-1(zu67); iaIs34 16.3 ± 0.4 8‡ 26 49 0.002‡ 
skn-1(zu67); iaIs34 18.7 ± 0.7 16‡ 30 59 <0.0001‡ 
daf-2(e1370) 29.6 +2.0  50 23  
daf-2(e1370) 32.6 +1.7  48 24  
daf-2(e1370) 34.9 +1.7  50 29  
daf-2(e1370); hif-1(ia04) 28.7 +3.1 -3¥ 54 15 0.77¥ 
daf-2(e1370); hif-1(ia04) 35.5 +1.6 9¥ 54 30 0.18¥ 
daf-2(e1370); hif-1(ia04) 35.3 +1.7 5¥ 54 30 0.9¥ 
daf-2(e1370); iaIs32 35.8 +3.2 16¥ 58 17 0.007¥ 
daf-2(e1370); iaIs32 25.2 +1.7 -16¥ 40 28 0.6¥ 
daf-2(e1370); iaIs34 31.5 +1.2 3¥ 54 21 0.6¥ 
daf-2(e1370); iaIs34 31.2 +2.0 2¥ 52 23 0.6¥ 
daf-2(e1370); iaIs34 27.8 +2.4 -10¥ 42 21 0.42¥ 
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* The longevity of was compared to wild-type N2, and the p values were calculated by 
log-rank tests.  
† The longevity of was compared to daf-16(mu86) worms, and the p values were calculated 
by log-rank tests. 
 ‡ The longevity of was compared to skn-1(zu67) worms, and the p values were calculated 
by log-rank tests. 
 ¥ The longevity of was compared to daf-2(e1370) worms, and the p values were calculated 
by log-rank tests.  
 
All of the experiments in Table S1 were conducted at 20oC on live bacterial food, as 
described in the Materials and Methods of the main text. 
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Table S2: Effects of hif-1 RNAi on the longevity of wildtype worms. 
strain 
Adult life span 
mean +S.E. 
Maximum 
lifespan 
Percentage v. 
control RNAi n p† value 
N2 (L4440 RNAi) 16.5 ± 0.7 28  45  
N2 (L4440 RNAi) 17.3 ± 0.7 28  42  
N2 (L4440 RNAi) 16.7 ± 0.5 26  66  
N2 (hif-1 RNAi) 19.5 ± 0.8 30 15 35 0.009 
N2 (hif-1 RNAi) 19.6 ± 0.9 32 16 43 0.0008 
N2 (hif-1 RNAi) 19.0 ± 0.7 28 12 39 0.02 
 
These lifespan assays were performed at 20ºC.   
† The p value was calculated by log-rank test as a comparison to N2 worms treated with 
control RNAi (L4440). 
Supplemental Methods for Table S2. 
hif-1 RNAi constuct and lifespan analyses on RNAi bacterial food:  To generate the hif-1 
RNAi construct, a 1.4 kb hif-1 cDNA fragment was excised from pHJ06 (Jiang et al. 2001 
PNAS 98: 7916) and was inserted into the pPD129.36 (L4440) vector at the EcoRV and 
XhoI sites. The hif-1 RNAi construct was transformed into HT115 bacterial strain. RNAi 
plates used in life span assay were prepared with 5mM IPTG and with no FuDR or 
antibiotics (Kamath et al 2001 Genome Biol 2: RESEARCH0002). The lifespan assays were 
performed at 20ºC. Young adult hermaphrodites which had been maintained at 20ºC on 
NGM plates and OP50 bacterial food were transferred to RNAi plates and allowed to lay 
eggs overnight. The L4 larvae grown from these eggs were transferred to fresh plates. Each 
plate included 20 – 25 animals, and at least 50 animals were used in each independent trial.  
The worms were transferred to new RNAi plates every two days for the first two weeks and 
every six days thereafter. Viability was scored every 2 days.  Worms that crawled off the 
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plates, burst at the vulva or died because progeny hatched in utero were excluded from final 
statistical analyses. Life span statistical analyses were carried out using JMP software 
(version 7.0) to determine the means and percentiles. 
 68 
Table S3.  Lifespan assays at 25 ºC on UV-irradiated bacterial food 
(OP50). 
strain 
Adult life span 
mean +S.E. 
Maximum 
lifespan 
Percentage v. 
N2 n p* value 
N2 15.9 ± 0.5 22  30  
N2 15.3 ± 0.5 20  41  
hif-1(ia04) 17.5 ± 0.4 22 13 33 0.001 
hif-1(ia04) 17.3 ± 0.4 26 11 72 0.0003 
 
* The p value was calculated by log-rank test as a comparison to N2 worms. 
 
Supplemental Methods for Table S3. 
To kill the bacterial food, standard NGM plates spotted with OP50 bacteria as 
described in the main text were exposed to UV light (302nm) for 15 minutes using a 
Benchtop UV transilluminator system (UVP). The death of UV irradiated bacterial food was 
confirmed by streaking the bacteria on LB agar plates.  For the experiments in Table S3, 
young adult hermaphrodites which had been maintained at 20ºC on NGM plates spotted with 
live OP50 bacterial food were allowed to lay eggs overnight on the UV-irradiated bacterial 
food. The L4 larvae grown from these eggs at 20ºC were transferred to fresh UV-irradiated 
plates and removed to 25ºC to perform the lifespan assays as described in the main text. 
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CHAPTER3. HIF -1-INDEPENDENT HYPOXIA 
RESPONSE SIGNALING MEDIATES AGING IN C.ELEGANS 
Abstract 
Hypoxia is associated with animal development and with the pathology of many 
age-related diseases, such as cancer, stroke and ischemia. Hypoxia signaling is important for 
animals to adapt to low oxygen tension. The components of hypoxia signaling are potential 
targets for the treatment of age-related diseases. However, the effects of hypoxia and the 
roles of hypoxia signaling in organismal aging are not well understood. Here we report that 
hypoxia slows aging in the nematode Caenorhabditis elegans. This prolongevity effect is not 
determined during development, but is exerted in adult life. In Chapter 2, we have shown that 
over-expression of HIF-1 increases longevity. Here we demonstrate that hypoxia can also 
extend life span through hif-1-independent pathways. Hypoxia promotes longevity in 
mechanisms distinct from the insulin-like signaling pathway. We present evidence that 
hypoxia induces inositol-requiring protein 1 (ire-1)-mediated unfolded protein response 
(UPR), and ire-1 is required for hypoxia-mediated lifespan extension. Thus, ire-1-mediated 
UPR is involved in the hif-1-independent hypoxia response that slows aging in C. elegans. 
 
 70 
INTRODUCTION 
Oxygen availability influences many cellular processes including energy metabolism, 
proliferation and cell death. Oxygen deprivation (hypoxia) is one of the common conditions 
shared by cells during many human diseases, such as cancer, stroke and ischemia. 
Interestingly, the incidence of these disorders increases with aging, which suggests that the 
networks governing oxygen homeostasis and aging may be intertwined. However, the 
interrelationship between hypoxia response signaling pathways and aging is not well 
understood. 
Hypoxia-inducible factor (HIF) transcription factors regulate most of the 
transcriptional changes during oxygen homeostasis in animals (SEMENZA 2007; SHEN et al. 
2005). The heterodimeric HIF complex is composed of two subunits, both of which contain 
basic-helix-loop-helix and PAS domains. HIFα  stability is acutely regulated by cellular 
oxygen levels and is dedicated to oxygen homeostasis. In normoxia, HIFα proteins are 
hydroxylated at specific proline residues by the EGLN family of 2-oxoglutarate 
dioxygenases. Hydoxylated HIFα is then degraded through the von-Hippel-Lindau 
(pVHL)-mediated proteosome pathway. Hypoxia suppresses the hydroxylation reaction and 
thus stabilizes HIFα (EPSTEIN et al. 2001). The HIF complex then activates a group of genes 
to facilitate hypoxia adaptation. In C. elegans, hif-1 encodes the ortholog of HIF alpha and is 
required for hypoxia adaptation during development (JIANG et al. 2001; PADILLA et al. 2002). 
C. elegans hif-1 is associated with heat stress response (TREININ et al. 2003), oxygen sensing 
behavior (CHANG and BARGMANN 2008) and neuronal development (POCOCK and HOBERT 
2008).  
We and others have established that hif-1 is one of the key stress response transcription 
factors that modulate aging in C.elegans (CHEN et al. 2009; MEHTA et al. 2009; ZHANG et al. 
2009). Honda et al showed that hypoxia (1% oxygen) increased lifespan in C.elegans , while 
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worms cultured in hyperoxia live shorter(HONDA et al. 1993). However, the role of hif-1 in 
regulating aging during hypoxia is elusive. In this study, we investigate the role of hypoxia 
and hypoxia signaling pathways in organismal aging in C.elegans. Although stabilization of 
HIF-1 protein promotes longevity, we demonstrate that hypoxia can extend adult lifespan in 
the absence of hif-1. Further, we show that the ire-1-mediated unfolded protein response is 
required for the pro-longevity effect of hypoxia. 
 
RERULTS 
HIF-1 is not necessary for hypoxia-mediated lifespan extension.  
The nematode C. elegans has a broad range of oxygen tolerance, and this is likely due 
in part to its small body size.  It can maintain near-normal metabolic rates at oxygen levels 
as low as 2 percent (VAN VOORHIES and WARD 2000). To explore the effects of hypoxia on 
aging in C.elegans, we first assayed the lifespan of worms cultured in 1% O2. We found that 
hypoxia treatment extended the mean lifespan of C.elegans by approximately 17% (Fig 1B 
and Table 1), indicating that oxygen deprivation and the resulting changes in cellular 
signaling and metabolism mediate a beneficial effect and delay aging. The hypoxia-inducible 
factor (HIF-1) pathway mediates most of the transcriptional changes in response to hypoxia 
in C. elegans (SHEN et al. 2005). In normoxia, HIF-1 protein is degraded through the 
evolutionarily conserved EGL-9/VHL-1 pathway. Hypoxia suppresses this degradation 
pathway and thus induces HIF-1 accumulation and activity. Our previous studies have shown 
that HIF-1 over-expression was sufficient to increases lifespan in C.elegans (ZHANG et al. 
2009). We considered the possibility that HIF-1 over-expression was the sole mechanism by 
which hypoxia slowed aging. To test this hypothesis, we assayed the lifespan of hif-1 mutant 
worms in hypoxia. hif-1 loss-of-function mutants have a superficially normal phenotype but 
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fail to adapt to hypoxia during development (JIANG et al. 2001). To avoid developmental 
defects in hypoxia, we raised the hif-1 mutant worms through the young adult stage in normal 
culture conditions before shifting to hypoxia and determining their lifespan. To our surprise, 
as shown in Figure 2A and Table 1, hypoxia treatment extended the adult lifespan of 
hif-1(ia04) worms by approximately 18%. 
We also asked whether hypoxia treatment during embryonic and larval stages would 
induce changes that would prolong adult lifespan. To test this hypothesis, we applied hypoxia 
to animals during embryogenesis and larval development. After they reached the young adult 
stage, we shifted the worms to normoxia and assayed their lifespan. These worms did not live 
longer when compared to worms without hypoxia treatment (Fig. 1C and Table 1). In 
contrast, the worms treated with hypoxia only after they reached young adult stage in 
normoxia lived 17% longer (Fig. 1D and Table 1). These studies showed that worms that are 
cultured in 1% oxygen during their adult lives do not receive further longevity effects from 
hypoxia treatment during embryonic and larval development. Since hypoxia treatment during 
adulthood increased longevity to similar degrees as during whole lifespan, in the following 
experiments, adulthood hypoxia treatment was employed in the lifespan assay. 
We further tested the effect of hypoxia on the transgenic worms carrying extra copies 
of the hif-1(P621G) transgene. Our prior work has demonstrated that the transgenic 
HIF-1(P621G) protein was stabilized in normoxia and that animals expressing HIF-1(P621G) 
exhibited increased longevity (ZHANG et al. 2009). As shown in Figure 2B, hypoxia 
treatment further extended the lifespan of long-lived HIF-1 over-expression transgenic 
worms by approximately 17%. Taken together, these results support a model in which 
hypoxia  promotes longevity via parallel pathways. HIF-1 stabilization increases longevity 
and stress resistance, and hypoxia also increases C. elegans adult lifespan through a HIF-1 
–independent pathway. 
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Hypoxia modulates longevity by a mechanism distinct from insulin-like 
signaling.  
DAF-2 insulin-like signaling is a well-established pathway that regulates longevity in 
C. elegans. Reduction-of-function mutations in the daf-2 insulin like receptor induce the 
nuclear localization of DAF-16/FOXO and dramatically increase lifespan and stress 
resistance. Conversely, loss-of-function mutations in daf-16 shorten lifespan (KENYON et al. 
1993; KIMURA et al. 1997; LIN et al. 2001; OGG et al. 1997). Previous studies found that 
daf-16 mRNA expression was induced by hypoxia in a hif-1-independent manner (SHEN et al. 
2005). We tested whether daf-16 was required for life span extension mediated by hypoxia. 
As illustrated in Figure 3A and Table 1, hypoxia extended the mean lifespan of daf-16(mu86) 
mutants by 28%. This indicates that daf-16 is not required for hypoxia-induced longevity in 
C. elegans. 
The heat-shock factor (HSF-1) transcription factor activates heat-shock proteins in 
response to heat and other forms of stress. Like DAF-16, HSF-1 is regulated by the DAF-2 
insulin-like receptor. Loss-of-function mutations in hsf-1 suppress lifespan extension in 
daf-2-deficient animals (HSU et al. 2003; MORLEY and MORIMOTO 2004). Earlier microarray 
studies by our research group demonstrated that several heat shock proteins were induced by 
hypoxia via hif-1-independent pathways (SHEN et al. 2005). It was, therefore, important to 
test the hypothesis that hsf-1 was required for hypoxia-induced lifespan extension. As 
illustrated in Figure 2B and Table 1, hypoxia increased lifespan of hsf-1(sy441) mutants by 
24%.  
SKN-1 mediates the phase-II detoxification pathway during oxidative stress (AN and 
BLACKWELL 2003), and mutation of daf-2 has been shown to increase nuclear localization of 
SKN-1 to extend longevity (TULLET et al. 2008). We tested the hypothesis that a 
loss-of-function mutation in skn-1 could abolish the pro-longevity effects of hypoxia 
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treatment. As shown in Figure 2C and Table 1, hypoxia extended the lifespan of skn-1(zu67) 
mutants by up to 25%.  
Having determined that DAF-16, HSF-1, and SKN-1, the three major stress-responsive 
transcription factors regulated by DAF-2, were not required for hypoxia-induced longevity, 
we tested the hypothesis that daf-2 mutants benefited from hypoxia. Indeed, as shown in 
Figure 2D, hypoxia treatment further extended the lifespan of long-lived daf-2(e1370) mutant 
worms. Taken together, these observations indicated that hypoxia induces longevity in 
mechanisms distinct from insulin-like signaling pathway. 
 
IRE-1 mediated unfolded protein response is required for hypoxia- 
mediated lifespan extension.  
In mammals, hypoxia has been shown to cause accumulation of unfolded protein in the 
endoplasmic reticulum (ER) and thereby activate the unfolded protein response (UPR) 
through three signaling pathway mediated by IRE1, PERK, and ATF6 (RON and WALTER 
2007). The Phsp-4::GFP transgene has been shown to be a reliable reporter of activation of 
the UPR in C. elegans (CALFON et al. 2002; YONEDA et al. 2004), and we asked whether 
hypoxia would induce Phsp-4::GFP expression.  Indeed, hypoxia significantly induced the 
expression of Phsp-4::GFP (Figure 4D), consistent with the expectation that hypoxia would 
elicit the UPR in C. elegans.  
We investigated the role of ire-1-mediated UPR in hypoxia-induced lifespan extension. 
ire-1 encodes an ER transmembrane protein that senses misfolded proteins in the ER lumen 
and activates the downstream transcription factor XBP-1 through alternative splicing. 
Activated XBP1 then regulates target gene expression to cope with ER stress (CALFON et al. 
2002). As shown in Figure 4H, the induction of Phsp-4::GFP expression was completely 
abolished by a loss-of-function mutation in ire-1 or xbp-1, suggesting that ire-1 signaling is 
 75 
essential for UPR induced by hypoxia (ANDERSON et al. 2009). As shown in Figure 5A and 
Table 1, a loss-of-function mutation in ire-1 completely abrogated the pro-longevity effect of 
hypoxia. Additionally, animals a carrying loss-of-function mutation in xbp-1 did not live 
longer in hypoxia (Figure 5B and Table1). In contrast, hypoxia treatment extended lifespan 
of mutants of pek-1, which encodes the C.elegans PERK homolog that functions in parallel 
to ire-1 to regulate UPR. Taken together, these results suggested that ire-1-mediated UPR 
was required for the hypoxia-mediated lifespan extension, but pek-1 did not have a critical 
role. 
To understand the relationship between UPR and HIF-1 in hypoxia-induced longevity, 
we asked whether ire-1 was required for hypoxia-induced lifespan extension in animals 
over-expressing HIF-1. As shown in Figure 6A, 6B and Table 1, reducing ire-1 or xbp-1 
expression by RNAi did not abolish the pro-longevity effect induced by HIF-1 
over-expression. These results support a model in which ire-1-mediated UPR functions in 
parallel to HIF-1 over-expression to modulate aging in hypoxia. 
 
DISCUSSION 
Numerous studies have suggested that the genes and pathways that modulate aging 
intersect with the signaling networks in response to adverse environmental conditions. The 
availability of oxygen, which is the final electron acceptor of aerobic respiration, is critical 
for the survival of all metazoans. Our study and previous studies demonstrated that hypoxia 
extends lifespan in C.elegans. Although hypoxia responsive signaling pathways, such as 
HIF-1, have been studied extensively in mammals, and many components of the pathways 
are conserved in C.elegans, their roles in hypoxia-mediated lifespan extension are unknown. 
We found that hif-1, which controls most of the transcriptional changes during hypoxia 
adaptation, is not essential for hypoxia-mediated lifespan extension. In addition, hypoxia 
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increases longevity in mechanisms distinct from insulin like signaling pathway. Instead, we 
found that hypoxia-activated UPR is required for the pro-longevity effect of hypoxia. These 
results suggested that hypoxia modulates aging through orchestrating multiple genetic 
pathways. 
Our data showed that hypoxia treatment in adulthood is necessary and sufficient for 
hypoxia-mediate lifespan extension. It has been clear that perturbation of lifespan-regulatory 
network during adulthood can modulate aging (CURRAN and RUVKUN 2007; DILLIN et al. 
2002a; HANSEN et al. 2008; HANSEN et al. 2007). Conversely, lifespan extension achieved by 
down-regulating some mitochondrial genes was specified during development, and inhibiting 
respiratory-chain components during adulthood only did not affect lifespan (DILLIN et al. 
2002b). Hypoxia treatment during development resulted in neuronal migration defect and 
altered behavior in C.elegans (CHANG and BARGMANN 2008; POCOCK and HOBERT 2008). 
Our results suggested that lifespan extension mediated by hypoxia can be dissociated from its 
roles in developmental specification. 
HIF-1 is a key regulator in hypoxia adaptation and is involved in many cellular 
processes, including glucose metabolism, angiogenesis and cell death. Recent studies 
established hif-1 as an important modulator of stress resistance and aging in C.elegans (CHEN 
et al. 2009; MEHTA et al. 2009). Thus, it is a surprise that loss-of-function mutation of hif-1 
does not abolish the hypoxia-mediated longevity effect. We hypothesize that induction of 
HIF-1 over-expression acts synergistically with other oxygen-sensitive signaling pathway(s) 
to modulate aging in hypoxia. We also found that the worms lived a longer life in 10% 
oxygen (unpublished data). On the other hand, it has been reported that hyperoxia (60% 
oxygen) shortened the lifespan. Therefore, it is possible that oxygen modulates aging through 
mechanisms that do not involve hif-1. 
Recent studies indicated that ER stress and protein homeostasis are important in aging 
(COHEN et al. 2006; STEINKRAUS et al. 2008; VISWANATHAN et al. 2005). Accumulation of 
unfolded/misfolded proteins in the ER lumen induces unfolded protein response through 
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three signaling pathways mediated by IRE1, PERK, and ATF6 (RON and WALTER 2007). We 
found that hypoxia induces ER stress and unfolded protein response in C.elegans. Our work 
demonstrated that lifespan extension by hypoxia in C.elegans requires functional signaling of 
IRE-1 and XBP-1. The fact that loss-of-function mutation of ire-1 or xbp-1 entirely abolished 
the pro-longevity effects of hypoxia underscores the importance of protein homeostasis 
during hypoxia adaptation.  
Our results indicate that IRE-1 and XBP-1 act in parallel to HIF-1 over-expression to 
modulate aging in C.elegans. A recent study from Kapahi research group demonstrated that 
loss-of-function mutation of hif-1 increased the lifespan in rich-food condition. The longevity 
effect of hif-1 mutant was dependent on functional ire-1-mediated UPR (CHEN et al. 2009). 
These results supported the hypothesis that HIF-1 over-expression and loss-of-function 
mutation act in different pathways to modulate aging in C.elegans. 
Our study underlines the complex interaction of signaling pathways that links oxygen 
homeostasis and aging. While multiple oxygen-sensing pathways, such as HIF-1, DAF-16 
and UPR are all induced by hypoxia in C.elegans, their roles in lifespan extension are distinct. 
Importantly, many components of oxygen-sensing pathways are potential therapeutic targets 
for treatment of hypoxia-related diseases, such as stroke, ischemia and cancer. Our results 
suggest that intervention of unfolded protein response pathway may prove particularly 
efficient in certain pathological conditions. 
 
 
MATERIALS AND METHODS 
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C. elegans strains 
The mutant alleles were as follows: LGI: daf-16(mu86)lf; LGII: daf-2(e1370) 
reduction-of-function, ire-1(v33)lf; LGIII: xbp-1(zc12)lf; LGIV: skn-1(zu67)lf; LGV: 
hif-1(ia04)lf; LGX: pek-1(ok275)lf.   
Life span assays 
All strains were maintained at 20oC for at least two generations prior to a life span assay. 
In order to avoid effects of hypoxia on food, standard NGM plates (60mm NGM plates 
spotted with 250 ul OP50 bacteria and allowed to grow at room temperature overnight) were 
irradiated by UV light. For each trial, at least 50 synchronized L4 or young adult worms were 
picked on UV irradiated plates at 25 to 30 worms per plate and cultured at 25 oC thereafter. 
Worms were removed to new plates every 2 days, and viability was scored. Worms that 
crawled off the plates, burst at the vulva or died because progeny hatched in utero were 
excluded from final statistical analyses. Life span statistical analyses were carried out using 
JMP software (version 7.0) to determine the means and percentiles. p values were calculated 
using the log-rank (Mantel-Cox) method. 
Hypoxia treatment 
Hypoxia (1% oxygen) was achieved by mixing room air and nitrogen in hypoxia 
chamber. UV irradiated NGM plates with experiment animals were placed in hypoxia 
chamber for 15 minutes to reach hypoxia. The plates were enclosed in air-tight 
polypropylene jars (Nalgene) balanced with 1% oxygen, and cultured in incubator (Precision) 
at 25 oC. The worms were censored every two days and removed to new NGM plates. The 
procedure of inspection and transfer was performed at room air within 10 minutes.  
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Microscopy 
To measure the expression of Phsp-4::GFP under normoxia or hypoxia, age 
synchronized L4 larvae of SJ4005 zcIs4[Phsp-4::GFP] or SJ30 ire-1(zc14), 
zcIs4[Phsp-4::GFP] were incubated in room air or hypoxia (1% oxygen) for 4 hours. The 
worms were allowed to recover for 2 hours before they were mounted on agar pads and 
imaged. Pictures were taken at DIC microscopy or fluorescence microscopy on a Nikon E800 
microscope connected to a Spot RT digital camera (Roche Diagnostics). 
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FIGURE LEGENDS 
Figure 1. Hypoxia signaling functions during adulthood to modulate aging in C.elegans. 
The proportion of animals remaining alive is plotted against adult animal age. Lifespan 
values are given in Table 1; assays were carried out in 1% oxygen or room air at 25ºC. (A) 
Schematic of the experimental protocol. Wild-type N2 worms were treated with hypoxia (1% 
oxygen) since embryo (B), or during embryonic and larvae stage (C) or adulthood (D) only. 
(B) Wild type N2 worms live longer in hypoxia (p<0.0001). (C) N2 worms develop to young 
adult in hypoxia do not live longer in nomorxia (p>0.8). (D) Hypoxia treatment during 
adulthood extends lifespan of N2 worms (p<0.0001). 
 
Figure 2. HIF-1 is not required for hypoxia-mediated lifespan extension. Hypoxia 
treatment (1% oxygen) since L4/young adult stage increases longevity of (A) hif-1(ia04) 
mutants or (B) animals carrying extra copies of hif-1(P621G) transgene. The proportion of 
animals remaining alive is plotted against adult animal age. Lifespan values are given in 
Table 1; assays were carried out in 1% oxygen or room air at 25ºC. 
 
Figure 3. Hypoxia modulates longevity in a mechanism distinct from insulin-like 
signaling to extend lifespan. Survival curves of mutant worms exposed to hypoxia during 
adulthood are shown, with proportion of animals alive plotted against adult age. Lifespan 
values are given in Table1; assays were carried out in 1% oxygen or room air at 25ºC. (A-C) 
Hypoxia treatment (1% oxygen) since L4/young adult stage extends lifespan of animals 
carrying loss-of-function mutation in (A) daf-16 (p<0.0001), (B) hsf-1 (p<0.0001), or (C) 
skn-1 (p<0.0001). (D) Hypoxia further increases the lifespan of long-lived daf-2 mutants 
(p<0.0001). 
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Figure 4. Hypoxia induces unfolded protein response. (A-H) Phsp::GFP expression in L4 
C.elegans after 4 hours exposure in normoxia or hypoxia (1% oxygen). Scale bar, 100 μm. 
 
Figure 5. IRE-1 mediated unfolded protein response is required for hypoxia longevity 
effect. (A-B) Loss-of-function mutation of ire-1(v33) (A) or xbp-1(zc12) (B) abolishes 
lifespan extension mediated by hypoxia. (C) Animals carrying loss-of-function mutation of 
pek-1(ok275) live longer in hypoxia. Survival curves of mutant worms exposed to hypoxia 
during adulthood are shown, with proportion of animals alive plotted against adult age. 
Lifespan values are given in Table1; assays were carried out in 1% oxygen or room air at 
25ºC. 
 
Figure 6. IRE-1 mediated unfolded protein response acts in parallel to HIF-1 
over-expression to modulate aging. Animals carrying hif-1(P621G) transgene live longer 
than wild-type worms when treated with control RNAi (A), ire-1 RNAi (B) or xbp-1 RNAi 
(C). The proportion of animals alive is plotted against adult age. Lifespan values are given in 
Table2; assays were carried out in room air at 25ºC. 
 
Figure 7. Genetic models depicting lifespan modulation by hypoxia. HIF-1 and UPR are 
both induced by hypoxia and both extend longevity. Alternatively, HIF-1 and an unknown 
pathway extend longevity in hypoxia, but animals that are defective for UPR components 
suffer more from hypoxic stress, offsetting the benefits of hypoxia.  
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Table 1. Statistic analysis of life span data for replicate experiments in the manuscript.  
Treatment 
Hypoxia* life span 
mean +S.E. (n) 
Nomoxia life span 
mean+S.E. (n) 
Percentage 
v. normoxia p value† 
N2 (hypoxia whole life) 19.5 ± 0.4 (33) 15.4 ± 0.5 (25) 27 <0.0001 
N2 (hypoxia whole life) 18.9 ± 0.4 (61) 17.3 ± 0.3 (51) 10 0.0005 
N2 (hypoxia whole life) 18.5 ± 0.3 (57) 16.4 ± 0.3 (45) 13 <0.0001 
N2 (adult hypoxia) 18.8 ± 0.4 (38) 15.9 ± 0.5 (30) 18 <0.0001 
N2 (adult hypoxia) 17.8 ± 0.3 (45) 15.4 ± 0.4 (41) 16 <0.0001 
N2 (adult hypoxia) 17.9 ± 0.4 (44) 15.3 ± 0.4 (37) 17 <0.0001 
N2 (larvae hypoxia) 17.3 ± 0.3 (60) 17.3 ± 0.3 (51) 0 0.9 
N2 (larvae hypoxia) 16.1 ± 0.3 (63) 16.4 ± 0.3 (45) -2 0.82 
hif-1(ia04) 19.9 ± 0.4 (50) 17.5 ± 0.4 (33) 14 <0.0001 
hif-1(ia04) 21.9 ± 0.4 (68) 17.3 ± 0.4 (72) 27 <0.0001 
hif-1(ia04) 20.2 ± 0.3 (53) 17.9 ± 0.3 (57) 13 <0.0001 
iaIs32 [Phif-1::hif-1 
(P621G)::myc] 
23.3 ± 0.5 (52) 20.1 ± 0.5 (48) 17 <0.0001 
daf-16(mu86) 15.6 ± 0.3 (60) 11.3 ± 0.3 (39) 38 <0.0001 
daf-16(mu86) 16.2 ± 0.4 (57) 12.7 ± 0.4 (55) 28 <0.0001 
daf-16(mu86);hif-1(ia04) 15.4 ± 0.4 (56) 12.0 ± 0.3 (54) 28 <0.0001 
hsf-1(sy441) 12.8 ± 0.3 (49) 10.3 ± 0.2 (40) 24 <0.0001 
hsf-1(sy441) 12.9 ± 0.3 (57) 10.3 ± 0.3 (56) 24 <0.0001 
skn-1(zu67) 18.6 ± 0.4 (50) 15.1 ± 0.4 (53) 23 <0.0001 
skn-1(zu67) 18.5 ± 0.4 (55) 14.8 ± 0.4 (47) 25 <0.0001 
daf-2(e1370) 39.2 ± 1.1 (58) 33.2 ± 0.9 (55) 18 <0.0001 
ire-1(v33) 12.1 ± 0.5 (49) 12.0 ± 0.6 (44) 1 0.83 
ire-1(v33) 11.2 ± 0.4 (47) 11.3 ± 0.4 (30) -1 0.84 
xbp-1(zc12) 12.9 ± 0.6 (28) 13.5 ± 0.4 (37) -4 0.65 
xbp-1(zc12) 11.9 ± 0.4 (46) 12.2 ± 0.4 (42) -2 0.69 
pek-1(ok275) 19.5 ± 0.4 (45) 16.4 ± 0.5 (43) 19 <0.0001 
pek-1(ok275) 18.7 ± 0.5 (42) 15.5 ± 0.5 (41) 21 <0.0001 
 
* Unless indicated otherwise, animals were grown in room air at 20ºC till L4/young adult 
stage before being subjected to hypoxia (1% oxygen) treatment at 25ºC. 
† The longevity of each strain was compared to wild-type, and the p values were calculated 
by log-rank tests. 
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Table 2: Effects of ire-1 and xbp-1 RNAi on the longevity of HIF-1 over-expression 
worms. 
strain 
Adult life span 
mean +S.E. 
Maximum 
lifespan 
Percentage 
v. control  n p* value 
N2 (L4440 RNAi) 13.3 ± 0.4 20  56  
IaIs32 (L4440 RNAi) 18.5 ± 0.4 24 27 51 <0.0001 
N2 (ire-1 RNAi) 11.1 ± 0.4 18  57  
IaIs32 (ire-1 RNAi) 14.6 ± 0.4 20 33 53 <0.0001 
N2 (xbp-1 RNAi) 10.1 ± 0.4 18  47  
IaIs32 (xbp-1 RNAi) 15.7 ± 0.4 22 51 53 <0.0001 
 
* The longevity of each strain was compared to wild-type, and the p values were calculated 
by log-rank tests. 
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Figure 1. Hypoxia signaling functions during adulthood to modulate aging in C.elegans. 
 
 
Figure 2. hif-1 is not essential for hypoxia-mediated lifespan extension. 
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Figure 3. Hypoxia modulates longevity by a mechanism distinct from insulin/IGF-1-like 
signaling. 
 
 
 
 
Figure 4. Hypoxia induces Phsp-4::GFP, a UPR marker in a ire-1 dependent manner. 
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Figure 5. ire-1 mediated unfolded protein response is required for hypoxia-modulated 
longevity effect. 
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Figure 6. ire-1 mediated UPR acts in parallel to HIF-1 over-expression to modulate aging. 
 
 
 
 
 
Figure 7. Genetic models depicting lifespan modulation by hypoxia. 
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CHAPTER 4. SWAN-1 interacts with EGL-9 to regulate 
HIF-1 activity in C. elegans 
A manuscript in preparation 
Yi Zhang, Zhiyong Shao, Qi Ye and Jo Anne Powell-Coffman 
Abstract 
Hypoxia-inducible factor (HIF) is the transcription factor that mediates the key 
transcriptional changes to enable oxygen homeostasis in animals. The α subunit of the 
heterodimeric HIF complex is acutely regulated by cellular oxygen levels and thus dictates 
oxygen-dependent transcriptional regulation. C. elegans HIF-1 is the ortholog of the 
mammalian HIFα subunit. HIF-1 protein is degraded in an oxygen-dependent manner via the 
evolutionarily conserved EGL-9/VHL-1 pathway. Recent studies demonstrated that EGL-9 
regulates both HIF-1 protein stability and HIF-1 activity. However, the molecular basis of 
how EGL-9 regulates HIF-1 transcriptional activity is still unclear. In order to identify the 
genes that repress HIF-1 activity, we carried out a forward genetic screen to search for 
mutants that over-expressed a HIF-1 target reporter gene. One of the alleles identified in this 
screen was mapped to swan-1, which encodes a WD repeat protein. Loss-of-function swan-1 
mutations increase HIF-1 activity but have little effect on HIF-1 protein levels. We present 
evidence that SWAN-1 binds directly to EGL-9. Therefore, our results establish SWAN-1 as 
a novel regulator of HIF-1 that suppresses HIF-1 activity in parallel to the VHL-1 mediated 
degradation pathway.  
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Introduction 
During development, homeostasis and diseases, aerobic organisms often experience 
low cellular oxygen conditions (hypoxia). In mammals, the hypoxia-inducible factor (HIF) 
transcription factor is the master regulator of transcriptional changes to enable the cellular 
and systemic adaptation to hypoxia (SEMENZA 2007b). HIF target genes are important in 
many hypoxia adaptation processes, including erythroproiesis, angiogenesis/vascular 
remodeling, glycolytic /mitochondrial metabolism and cell proliferation/survival. Hypoxia is 
involved in many human diseases, such as cancer, myocardial ischemia and stroke. Inhibitors 
of HIF or HIF target genes have been used as cancer chemotherapeutic agents, since HIF 
over-expression is often associated with survival of tumor cells in hypoxic 
microenvironments. Conversely, interventions that promote HIF activity may benefit patients 
afflicted with cardiovascular disorders. Therefore, elucidating the networks that regulate HIF 
may help develop novel therapeutic approaches to treat hypoxia-related diseases. 
The heterodimeric HIF-1 complex is composed of two subunits, both of which 
contain basic helix-loop-helix (bHLH) and PER-ARNT-SIM (PAS) domains that mediate 
dimerization and DNA binding. While the HIF-1 beta subunit can form complexes with other 
transcription factors, HIF-1α is sensitive to cellular oxygen levels and thus dictates HIF 
activity. Under normoxic conditions, HIF-1α is hydroxylated at proline residue(s) in the 
evolutionarily conserved oxygen-dependent-degradation (ODD) domain by the EGLN family 
(also known as PHD or HPH family) of 2-oxoglutarate dioxygenases which utilize O2 as a 
co-substrate. Hydroxylated HIF-1α is bound by the von Hippel-Lindau protein (pVHL), 
which in turn recruits a ubiquitin protein ligase complex that targets HIF-1α for proteasomal 
degradation. When the oxygen concentration is limited (hypoxia), this suppresses the 
hydroxylation reaction and hence stabilizes HIF-1α (EPSTEIN et al. 2001).  
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The nematode Caenorhabditis elegans has proven to be a powerful model to decipher 
the evolutionarily conserved signaling pathways that regulate hypoxia response and 
hypoxia-inducible factor (EPSTEIN et al. 2001; JIANG et al. 2001; SHEN et al. 2006). C. 
elegans hif-1, aha-1, egl-9, and vhl-1 genes are orthologous to mammalian HIF-1α, HIF-1β, 
EGLN, and VHL genes, respectively (EPSTEIN et al. 2001; JIANG et al. 2001; 
POWELL-COFFMAN et al. 1998). The stability of HIF-1 protein is controlled by the 
evolutionarily conserved EGL-9/VHL-1 pathway (EPSTEIN et al. 2001).  
Prior studies demonstrated that in addition to modulating stability, there are 
mechanisms regulating transcriptional activity of HIF-1 in C.elegans. Many treatments or 
mutations that eliminate oxygen-dependent degradation of HIF-1 protein do not abolish 
EGL-9-mediated repression of HIF-1 transcriptional activity (BISHOP et al. 2004; SHAO et al. 
2009; SHEN et al. 2006). These data suggested that EGL-9 acts as an oxygen sensor in the 
oxygen-dependent degradation pathway and also attenuates HIF-1 activity independent of 
VHL-1 (SHEN et al. 2006). In addition, loss-of-function mutations in the rhy-1 gene, whose 
expression is regulated by HIF-1, cause a modest increase of HIF-1 protein, but promote 
expression of some HIF-1 target genes at levels much higher than in vhl-1 mutants, 
suggesting that RHY-1 functions in a negative feedback loop to inhibit HIF-1 transcriptional 
activity (SHEN et al. 2006). Thus, the genetic data suggest that HIF-1 transcriptional activity 
is repressed by both RHY-1, a transmembrane protein, and EGL-9.  This pathway(s) does 
not require EGL-9 hydoxylase activity (SHAO et al. 2009), but the molecular mechanisms are 
largely unknown. 
In this study, we identify a novel regulator of HIF-1 from an EMS mediated enhancer 
screen designed to identify mutations that promoted HIF-1 activity (SHEN et al. 2006).  We 
identified new alleles of egl-9 and rhy-1 and the ia50 allele, which mapped to a region of the 
genome that had not been previously implicated in HIF-1 regulation.  The ia50 allele 
mapped to swan-1(F53C11.8), a gene that encodes a WD-repeat protein of the AN11 family 
(YANG et al. 2006). We further characterized ia50 and a deletion allele of swan-1, and we 
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found that swan-1 was required to repress expression of HIF-1 targets but had little effects on 
HIF-1 protein levels. Double mutants lacking vhl-1 and swan-1 function have a higher 
expression level of HIF-1 target genes than either single mutant. Using yeast two-hybrid and 
pull down assays, we showed that SWAN-1 physically interacted with EGL-9. These data 
support a model in which SWAN-1 inhibits HIF-1 localization or transcriptional activity. 
 
Materials and Methods 
Culture of C.elegans and strains 
All strains were maintained at 20°C on nematode-growth-medium (NGM) plates spotted with 
OP50 bacteria unless otherwise noted (BRENNER 1974). The wild type strain used for all 
experiments were N2 Bristol (BRENNER 1974). The mutant alleles were as follows: LGII: 
rhy-1(ok1402) lf, LGV: hif-1(ia04) lf, swan-1(ok267) lf, egl-9(sa307) lf; LGX: vhl-1(ok161) 
lf. To build the mapping strain ZG196, the Hawaiian strain CB4856 (DAVIS et al. 2005) was 
crossed to ZG119 iaIs07[Pnhr-57::gfp + unc-119(+)] IV; vhl-1(ok161) X. The F2 
hermaphrodites from this cross that exhibited strong GFP expression were then crossed back 
to the Hawaiian strain. The procedure was repeated 6 times until all the single nucleotide 
polymorphisms used in this study were confirmed as the Hawaiian pattern.  
EMS mutagenesis screen 
The forward genetic screen was performed as described previously (SHEN et al. 2006). 
Briefly, ZG119 iaIs07[Pnhr-57::gfp + unc-119(+)] IV; vhl-1(ok161) X animals were 
mutagenized with EMS, and the F2 progeny were screened for dramatically increased 
expression of the Pnhr-57:: GFP reporter (SHEN et al. 2006) using fluorescent stereo 
microscopy. The ia50 mutant allele was outcrossed twice to the parental strain prior to any 
further mapping or characterization. 
Mapping of ia50 to the swan-1 locus 
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Chromosome and interval mapping were performed as described by Davis et al (DAVIS et al. 
2005) with some modification. Briefly, ZG196 males (carrying SNPs from the Hawaiian 
strain) were crossed to ZG359 ia50; iaIs07[Pnhr-57:: gfp + unc-119(+)] IV; vhl-1(ok161) X. 
Fifty F2 animals exhibiting the vhl-1, swan-1 double mutant phenotype (of strong GFP 
expression in hypodermis, intestine and pharynx) and fifty animals exhibiting the vhl-1 single 
mutant phenotype (strong GFP expression only in intestine) were picked into separate tubes, 
and genomic DNA was prepared. Analysis of the divergent SNPs showed enrichment of 
Bristol bands in mutant lanes and an enrichment of Hawaiian bands in non-mutant lanes for 
SNPs lying between -5 and +13 mu on chromosome V. For interval mapping, individual 
self-progeny of ZG359/ZG196 F1 hermaphrodites (described above) with the swan-1, vhl-1 
double mutant phenotype were picked into a 96-well plate to prepare the genomic DNA.  
Analysis of four SNPs (-5, +1, +6, +13) (DAVIS et al. 2005) indicated 27/96 mutants were 
Hawaiian at one or more SNPs. Of those 27 mutants, 25/27 had the Hawaiian SNP at -5 mu; 
8/27 had the Hawaiian SNP at +1 mu; none had the Hawaiian SNP at +6 mu; and 2/27 had 
the Hawaiian SNP at +13 mu. This placed ia50 close to +6 mu. We then used SNP 
R10D6(+5.83 mu) and pkP5086(+6.42 mu) to do three point mapping. Among 960 worms 
over-expressing the reporter examined, 3/960 had the Hawaiian SNP at +5.83 mu, and 9/960 
had the Hawaiian SNP at +6.42 mu. Of note, all mutants that carried the Hawaiian SNP at 
+5.83 mu also carried the Hawaiian SNP at +6.42 mu. This placed ia50 at +5.67 mu. 
Transgenic animals 
Bacterial strains containing cosmids used for transformation were kindly provided by the 
Sanger Institute (United Kingdom).  The swan-1 plasmids were gifts from Dr. Erik 
Lundquist at University of Kansas (YANG et al. 2006). Plasmid or cosmid DNA was 
extracted from 4 ml bacteria media using a mini-prep plasmid preparation kit (Qiagen) and 
were confirmed by restriction enzyme digestion. To generate extrachromosomal arrays of 
transgenes, DNA (30 ng/uL plasmid DNA or 10 ng/uL cosmid DNA) was microinjected into 
young adult ia50;vhl-1(ok161);Pnhr-57::GFP mutant hermaphrodite germlines, following 
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standard procedures (EPSTEIN 1995). The rol-6 plasmid pRF4 was used as the coinjection 
marker (MELLO et al. 1991). 
RNA interference 
RNAi was performed as previously described (ZHANG et al. 2009). Bacterial strains 
containing RNAi construct were from Ahringer library (KAMATH et al. 2001). 
Egg-laying defect assay 
To quantitate the egg-laying defect, late L4 wild-type or mutant worms were removed to 
NGM plates spotted with OP50 bacteria. After culture at 20 ºC for 24 hours, the worms were 
inspected under microscopy (400×) to count the number of eggs held in utero. At least 10 
worms were inspected for each strain. Student t-test was used to calculate the p-value. 
Brood size assay 
Synchronized worms were obtained from overnight egg laying and allowed to develop at 
20ºC. Individual L4 animals were removed to NGM plates with single worms per plate. The 
worms were allowed to lay eggs for 24 hours. On subsequent days each worms was 
transferred to a new NGM plate and allowed to lay eggs for 24 hours until no eggs were 
produced. The number of viable progeny was scored by counting hatched larvae after 48 
hours. 
Western blots: 
To assay Pnhr-57::GFP or HIF-1::HA expression, 40 – 100 worms from synchronized 
populations of L4 animals or young adults were boiled in 1x SDS buffer [50mM Tris-HCl 
PH6.8, 10%(v/v) glycerol, 2% (w/v) SDS, 100mM DTT, 0.1% (w/v) bromphenol blue] for 
10  minutes before loading to a 10-12% polyacrylamide gel for electrophoresis. After 
separation, proteins were transferred to nitrocellulose membranes.  The blots were probed 
with monoclonal antibodies: GFP antibody (from Roche) at 1:1000 dilution; HA antibody 
(from Cell Signaling Technology, clone 6E2) at 1:1000 dilution; Mouse anti-myc ascites 
(clone 9E10) from the Developmental Studies Hybridoma Bank at 1:1000 dilution, or 
AHA-1 antibody (produced in ISU Hybridoma Facility)  (JIANG et al. 2001) at 1:100 
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dilution. The secondary antibody (goat anti-mouse IgG+IgM from Bio-rad) was diluted 
1:3000. The relative intensity of protein bands were quantified by Image J software.  The 
statistical significance of differences was assessed by t-tests. 
Quantitative RT-PCR:  
Total RNA was isolated from synchronized populations of L4 or young adult stage worms 
using Trizol reagent (Invitrogen).  RNA samples were treated by RNase free DNase 
(Promega) before being reverse transcribed to complementary DNA using Oligo(dT18) 
primers and AffinityScript reverse transcriptase (Stratagene). Quantitative RT-PCR was 
performed using the iQ SYBR GREEN supermix (Bio-Rad) real-time PCR system, and each 
reaction included cDNA prepared from 50-100ng total RNA.  The primers for K10H10.2 
and inf-1 have been published previously (SHEN et al. 2006).  The standard curve method 
was used to analyze the expression levels.  inf-1 is not regulated by hypoxia and was used as 
an input control (SHEN et al. 2006).  At least three biological replicates were analyzed for 
each experiment, and each PCR reaction was performed in duplicate.  Student t-tests were 
used to assess statistical significance of differences.  
Yeast two-hybird assay 
The coding region of the C. elegans egl-9 catalytic domain was generated by PCR and fused 
in frame to the GAL4  DNA-binding domain in the yeast expression vector pGBKT7 (bait). 
This construct did not result in autoactivation.  The swan-1 yeast two-hybrid construct (in 
the pACT2 prey vector) was described in a prior study and was kindly provided by E. 
Lundquist (YANG et al. 2006). 
To assay for protein-protein interactions between the SWAN-1 and EGL-9 proteins, we used 
the MatchmakerTM GAL4 Two-Hybrid systems (Clonetech). In this system, the 
transcriptional activation domain (AD) and the DNA binding domain (BD) of the yeast 
GAL4 transcription activator are encoded by two different plasmids, termed pACT2 and 
pGBKT7, respectively. Each plasmid encodes a selectable marker. pACT2 uses leucine as 
selection marker, and pGBKT7 uses tryptophane as selection marker.  The yeast strain used 
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in this system, Saccharomyces cerevisiae strain AH109, encodes four reporter genes, HIS3 
(imidazoleglycerol phosphate dehydratase, which catalyzes the sixth step in histidine 
biosynthesis), ADE2 (phosphoribosylamino-imidazole-carboxylase in the biosynthetic 
pathway of adenine), MEL1 (α-galactosidase) and lacZ (ß-galactosidase), under the control of 
distinct GAL4 upstream activating sequences and TATA boxes. The yeast strain AH109 was 
cotransformed with two hybrid plasmids (pACT2 plasmid carrying swan-1 sequence and 
pGKT7 carrying egl-9 sequence) by the polyethylene glycol-lithium acetate method (GIETZ et 
al. 1992; SCHIESTL and GIETZ 1989). As controls, the swan-1 plasmid was cotransformed 
with pGBKT7, and the egl-9 plasmid was cotransformed with pACT2. Both pGBKT and 
pACT2 were also cotransformed into the yeast strain AH109. Yeast cells were grown in 
SD-agar plates lacking histidine, leucine and tryptophane (medium stringency selection) to 
screen for expression of HIS3. Twenty His+ colonies were grown in 2 ml of liquid 
SD-medium lacking histidine, leucine, and tryptophane shaken at 30°C for 24 h. Ten-fold 
serial dilutions of the cultures were made, and 5 µl of each dilution was plated onto 
SD-medium lacking histidine, adenine, leucine, tryptophane and containing 
X-α-galactosidase plates (high stringency selection). These plates were incubated at 30°C for 
3 days to screen for expression of ADE2 and MEL1. 
Pull-down assay 
The transgenic line expressing SWAN-1::GFP was kindly provided by Dr. Erik Lundquist 
(YANG et al. 2006). Pswan-1::swan-1::gfp transgenic worms were cultured on enriched 
peptone plates (1.2g NaCl, 20g peptone, 25g agar in 1L water. Autoclave. Cool to 55ºC, then 
add 1ml of 5mg/ml cholesterol, 1ml of 1M MgSO4 and 25ml of 1M potassium phosphate, pH 
6.0) spotted with NA22 bacteria. The collected worms were suspended in extraction buffer 
[100 mM PIPES, pH 6.0, 100 mM NaCl, 3 mM MgCl2, 1 mM EGTA, a mM dithiothreitol 
(DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), 0.5% Triton X-100, Complete 
Protease Inhibitor Tablets (Roche), and phosphatase inhibitors (5 mM NaF and 1 mM 
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Na3VO4)]. The worm lysates were prepared by passing through a French press cell disrupter 
(Thermo Electron Corporation) at 8000 psi three times and cleared by centrifugation.  
To perform the pull down assay, 20 ul protein G Sepharose beads were preloaded with 
anti-GFP monoclonal antibody (Roche). After 4 hrs, the beads were washed with extraction 
buffer for three times and incubated with worm lysates at 4ºC for 4 hrs. The beads were 
washed three times in extraction buffer and incubated with 200 ul bacteria lysates expressing 
Maltose Binding Protein (MBP) fused EGL-9 at 4ºC for 4 hrs. The beads were washed three 
times in extraction buffer and then boiled in 25 ul SDS loading buffer for 10 min. The 
supernatants were analyzed by SDS-PAGE and Western-blots using anti-MBP (NEB) 
antibody. 
 
Results 
ia50 allele activates HIF-1 activity in vhl-1 mutants 
We designed an enhancer screen to search for the genes that inhibit HIF-1 activity. To 
facilitate the quick recovery of mutations in genes of interest, we have developed a visual 
system in which a GFP reporter was fused to the promoter of a HIF-regulated gene, nhr-57. 
This reporter has proven to be a reliable indicator of HIF function (SHEN et al. 2006). In 
animals expressing wild-type levels of HIF-1, the Pnhr-57::GFP signal was invisible in room 
air conditions under our fluorescent microscopy. The GFP signal increased in either 
vhl-1(ok161) or egl-9(sa307) mutants, consistent with the finding that HIF-1 was stabilized 
in both mutants (EPSTEIN et al. 2001; SHEN et al. 2006). In vhl-1(ok161) mutants, the GFP 
reporter was increased in the intestine but invisible in the hypodermis and pharynx (Figure 
1E). However, the Pnhr-57:: GFP signal increased dramatically in hypodermis, pharynx and 
intestine in egl-9(sa309) mutants (SHEN et al. 2006).  Prior studies have established that 
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EGL-9 represses HIF-1 activity, in addition to its central role in VHL-1-dependent 
degradation of HIF-1. To identify the genes act in concert with EGL-9 to inhibit HIF-1 
activity, we used EMS to mutagenize vhl-1(ok161) mutants and screened for F2 progeny with 
a Pnhr-57::GFP expression phenotype similar to that in egl-9 loss-of-function mutants. 
We isolated several mutants that increased expression of the Pnhr57:GFP reporter in 
the vhl-1(ok161) background. Complementation tests revealed that 3 of the mutations were 
new alleles of rhy-1, a HIF-1 regulating gene identified previously in our lab (Table 1) (SHEN 
et al. 2006). One of the mutant alleles, ia50, complemented both rhy-1 (ok1402) and 
egl-9(sa307), suggesting that it defined a new regulator of HIF. The enhanced GFP 
expression phenotype of ia50 was completely recessive and segregated as a single locus in a 
Medelian fashion. Interestingly, when we tried to outcross the vhl-1 mutant allele from ia50, 
all progeny (F2) that over-expressed the reporter were vhl-1 -/- mutant. This suggests that the 
effects of the ia50 mutation are only visually detectable when HIF-1 protein is not 
destabilized by the VHL-1 pathway. 
We also noticed egg-laying defects in ia50;vhl-1(ok161) mutant worms (Figure 1H, I), 
that were reminiscent of egl-9 mutants.  Strong loss-of-function of egl-9 cause worms to 
hold their eggs in utero for longer than wild-type worms (Figure 1I), and this is suppressed 
by a loss-of-function mutation in hif-1, suggesting that the egg-laying defect requires 
enhanced HIF-1 activity (SHEN et al. 2006). In addition, similar to egl-9 mutants, 
ia50;vhl-1(ok161) mutants had decreased brood size (Figure 1J). Taken together, these 
results indicated that the ia50 allele further increased HIF-1 activity in vhl-1 mutants to cause 
an phenotype similar to that seen in egl-9 strong loss-of-function mutants.. 
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ia50 is a loss-of-function mutation in swan-1(F53C11.8) 
We mapped ia50 using a rapid single nucleotide polymorphism (SNP) method 
modified from Davis et al. (DAVIS et al. 2005). This method placed ia50 close to + 6 mu on 
chromosome V (detailed in materials and methods). Three point mapping using two SNP 
markers near ia50 [+5.83 and +6.42 mu (Table 2)] refined the location of ia50 to + 5.67 mu 
on chromosome V ( Figure 2A ).  
We then screened cosmid DNA in that genetic interval to determine which genomic 
DNA fragment could rescue the ia50 mutant phenotype and repress Pnhr-57::GFP 
expression. One cosmid clone, F53C11 suppressed Pnhr-57::GFP expression in the 
hypodermis and pharynx (data not shown). The genes on cosmid F53C11 included swan-1 
(F53C11.8). swan-1 had previously been shown to encode a WD repeat protein and to be 
involved in regulation of Rac GTPases in neurons (YANG et al. 2006). Interestingly, 
SWAN-1::GFP fusion protein has been shown to be expressed in all cells except in intestine 
(YANG et al. 2006). This expression pattern is complementary to the Pnhr-57::GFP 
expression in vhl-1(ok161) mutants.  
Sequencing the swan-1 locus in ia50 mutants revealed a G to A conversion at the 
splice acceptor site of intron 2 ( Figure 2A ).  To investigate the consequences of this 
mutation, we sequenced cDNA from ia50 animals, and we determined that of the ia50 
mutation resulted in a swan-1 transcript that lacked intron 2.  This missplicing caused a 
frameshift and introduced an early stop codon (Fig. 2A). The truncated SWAN-1 protein 
lacks 6 of its 8 WD repeat domains (Figure 2A). Furthermore, RNA-mediated interference 
(RNAi) of swan-1 increased the expression of Pnhr-57::GFP in wild-type as well as in 
vhl-1(ok161) mutant worms (Figure 2B). 
 These data indicated that a loss-of-function mutation in swan-1 could cause 
over-expression of HIF-1 target genes in conditions in which HIF-1 was stable.  To further 
test this, we assayed Pnhr-57::GFP expression in swan-1(ok267);vhl-1(ok161) double 
 102 
mutants.  The swan-1(ok267) allele deletes sequences encoding 223 amino acid residues 
and is predicted to be a severe loss-of-function allele.  These animals over-expressed the 
Pnhr-57::GFP HIF-1 reporter, as assayed by fluorescent microscopy (data not shown) and 
immunoblots (Figure 3A). Moreover, swan-1(ok267) failed to complement ia50 (data not 
shown), providing further evidence that the two mutations mapped to the same locus.  
We noticed that immediately downstream of swan-1, there is another gene that 
encodes a WD repeat protein named SWAN-2 (F53C11.7). SWAN-2 is 45% identical at the 
amino acid level to SWAN-1 (YANG et al. 2006).  To test the hypothesis that swan-2 also 
regulated expression of the HIF-1 reporter, we assayed expression of Pnhr-57::GFP in 
animals treated with swan-2 RNAi.  As shown in Figure 2B, swan-2 RNAi had no effect.  
We conclude that swan-1, but not swan-2, regulates expression of HIF-1 target genes, as 
assayed by Pnhr-57::GFP expression and egg laying defects. 
 
SWAN-1 suppresses HIF-1 activity via a VHL-1-independent pathway. 
To more fully understand the swan-1 mutant phenotype, we quantitated the expression 
of HIF-1 target genes in wild-type animals and in animals that lacked oxygen-dependent 
degradation of HIF-1.  We chose to assay three HIF-1 targets, Pnhr-57:GFP, F22B5.4 
mRNA, and K10H10.2 mRNA, because each of these HIF-1 targets have been characterized 
in other studies (SHEN et al. 2005; SHEN et al. 2006) We used immunoblots to quantitate the 
expression of Pnhr-57::GFP. As shown in Figure 3A, swan-1(ok267) mutant worms 
expressed Pnhr-57::GFP at levels 5 times higher than in wild type. We further employed 
quantitative RT-PCR to assay the expression of K10H10.2 and F22B5.4 mRNAs. Previous 
studies had shown that the K10H10.2 and F22B5.4 genes were induced by hypoxia in a 
hif-1-dependent manner (SHEN et al. 2005). As shown in Figure 3 B and C, the swan-1(ok267) 
mutation did not change the mRNA level of K10H10.2 and caused increase in F22B5.4 
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mRNA by 3.7 fold. The increase of F22B5.4 mRNA was not significant (p = 0.3) (Fig. 3B, 
C). 
We further characterized the effects of swan-1 mutation on HIF-1 activity by 
analyzing double mutants lacking both swan-1 and vhl-1 functions. Characterization after the 
genetic screen had demonstrated that swan-1(ia50) mutation in vhl-1 mutants caused 
increased expression of Pnhr-57::GFP in the pharynx and hypodermis as detected by 
fluorescence (Fig. 1F). As shown in Figure 3D, in vhl-1(ok161) animals, the swan-1(ok267) 
allele increased Pnhr-57::GFP protein expression 2.4 fold. Analysis of K10H10.2 and 
F22G.5.4 mRNA levels by RT-PCR revealed a similar pattern. Expression of K10H10.2 and 
F22G5.4 mRNA increased 8 fold and 2 fold in swan-1(ok267); vhl-1(ok161), respectively, 
when comparing to vhl-1(ok161) mutants (Figure 3E, F). 
To address whether SWAN-1 regulated HIF-1 protein expression, we assayed protein 
levels of HIF-1::tag minigene (ZHANG et al. 2009). The epitope-tagged hif-1 encodes HIF-1a 
isoform and can rescue the HIF-1 function in hif-1 mutants (ZHANG et al. 2009). As shown in 
the immunoblots in Figure 3G, the swan-1 mutation did not change the expression of HIF-1 
protein. Similarly, swan-1(ok267);vhl-1(ok161) double mutants did not increase the 
HIF-1::tag protein level more than vhl-1-deficient worms (Fig. 3G). Collectively, these data 
show that loss-of-function mutations in swan-1 do not alter HIF-1 protein levels, but they do 
increase expression of HIF-1 targets. 
 
SWAN-1 interacts with EGL-9 to regulate HIF-1 activity 
 In prior studies, we had discovered that EGL-9 has multiple functions, and it regulates 
HIF-1 activity via a novel mechanism that does not require EGL-9 hydroxylase activity 
(SHAO et al. 2009).  We hypothesized that SWAN-1 might interact with EGL-9 to repress 
HIF-1 function.  To test this, we first tested whether SWAN-1 and EGL-9 acted in the same 
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pathway by measuring the expression of Pnhr-57::GFP in worms carrying loss-of-function 
mutations in swan-1 and egl-9. As shown in Figure 4A, swan-1(ok267);egl-9(sa307) mutants 
showed Pnhr-57::GFP expression levels comparable to those in egl-9(sa307) worms. This 
suggested that SWAN-1 regulates HIF-1 activity in the same pathway as EGL-9. 
To test the hypothesis that SWAN-1 binds to EGL-9 directly, we employed yeast 
two-hybrid assays. The GAL-4 DNA binding domain was fused to SWAN-1, and the GAL-4 
activation domain was fused to the EGL-9 catalytic domain. When these two fusion proteins 
were co-expressed, genes downstream of the GAL-4 enhancer sequences were expressed, as 
assayed by growth on auxotrophic media and by beta-galactosidase expression. As shown in 
Figure 4B, the presence of swan-1 and egl-9 catalytic domain fusion specifically activated 
both HIS5 expression and lacZ expression in the yeast two-hybrid system.  
To further confirm the physical interaction of SWAN-1 and EGL-9, we purified 
either GFP (as control) or SWAN-1::GFP from transgenic worms and assayed their 
interaction with bacterially expressed EGL-9. As shown in Figure 4C, GFP tagged full length 
SWAN-1 specifically pulled down the MBP tagged EGL-9 protein. 
 
DISCUSSION 
Hypoxia-inducible factors play key roles in the regulation of oxygen homeostasis 
during development and pathological conditions (SEMENZA 2007b; SHEN et al. 2005). C. 
elegans hif-1, orthologous to mammalian HIF α genes, regulates most of the transcriptional 
changes in response to oxygen deprivation (SHEN et al. 2005). HIF-1 protein is regulated by 
the evolutionarily conserved EGL-9/VHL-1 pathway, and in normoxia hydroxylated HIF-1 is 
targeted to proteasomal degradation (EPSTEIN et al. 2001). Recent studies suggested that 
some regulatory networks modulate HIF-1 activity in parallel to the oxygen-dependent 
degradation pathway (BISHOP et al. 2004; SHAO et al. 2009; SHEN et al. 2006). Employing 
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genetic approaches, we report here that SWAN-1 attenuates HIF-1 activity in mechanisms 
distinct from VHL-1-dependent degradation pathway. 
We first isolated an allele of swan-1 from a genetic screen designed to identify genes 
that inhibit HIF-1 activity. Subsequent mapping revealed a point mutation that disrupts the 
correct splicing of swan-1 mRNA. An existing deletion mutation of swan-1 largely 
recapitulates the phenotype of increased HIF-1 target reporter. The isolated swan-1 allele 
failed to complement the existing swan-1 deletion allele in inhibiting expression of HIF-1 
target gene. Loss-of-function mutations of swan-1 increased expression of HIF-1 target genes 
but did not alter the HIF-1 protein level. Analysis of double mutants lacking both swan-1 and 
vhl-1 function demonstrated that loss-of-function mutation of swan-1 can further promote 
HIF-1 transcriptional activity in vhl-1 mutants without changing HIF-1 protein expression. 
We also found that SWAN-1 physically interacted with EGL-9 in yeast two-hybrid and 
pull-down assays.  These results establish SWAN-1 as a novel HIF-1 regulator that 
normally inhibits HIF-1 transcriptional activity in parallel to VHL-1-mediated pathway that 
controls HIF-1 protein level. 
swan-1 encodes a WD-repeat protein that has been reported to regulate Rac GTPase 
activity in C. elegans (YANG et al. 2006). SWAN-1 physically interacts with both Rac and 
UNC-115/abLIM, a Rac regulator. Over-expression of SWAN-1 suppresses Rac activity 
(YANG et al. 2006). Expression of Rac1 was shown to suppress HIF-1 protein expression in 
hypoxic Hep3B, HEK293, and NIH3T3 cells (HIROTA and SEMENZA 2001). Our studies to 
date do not indicate that Rac family members control HIF-1 levels as assayed in whole 
animal lysates (data not shown).  Thus, the interactions between SWAN-1 and Rac family 
members in migrating cells may not influence HIF-1 signaling as assayed in whole animals. 
WD-repeat proteins have been found in all eukaryotes and they form a large family 
with diverse functions (LI and ROBERTS 2001; SMITH et al. 1999). The WD-repeat domain 
folds into a beta propeller and often serves as a platform on which multiple protein 
complexes assemble reversibly (LI and ROBERTS 2001). Our data demonstrated that 
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SWAN-1 physically interacted with EGL-9. Intriguingly, Morg1, a WD-repeat protein in 
mammals has been found to form a complex with PHD2/EGLN3 to suppress HIF-1 activity 
(HOPFER et al. 2006). Amino acid sequence analysis demonstrated that SWAN-1 and Morg1 
belong to different WD repeat protein families. It is interesting to see whether the functions 
of C. elegans SWAN-1 and mammalian Morg1 are conserved.  
It waits to be determined how the interaction between SWAN-1 and EGL-9 
contributes to suppressing HIF-1 activity. One possibility is that SWAN-1 forms a complex 
with HIF-1 and EGL-9, and may sequester HIF-1 from entering the nucleus. Another 
attractive model is that SWAN-1 may be involved in transcriptional repression. Recent 
studies have shown that WD-repeat proteins play important roles in chromatin remodeling 
and gene regulation (SUGANUMA et al. 2008b). Several WD-repeat proteins, including 
WDR5, RbBP5 and RbAp48, are components of histone modification complexes. WDR5 is 
associated with a SET-domain-containing histone methyltransferase as well as several 
histone acetyltransferases (DOU et al. 2006; MENDJAN et al. 2006; SUGANUMA et al. 2008a; 
WYSOCKA et al. 2005). RbAP48 is component of several chromatin-regulating complexes 
including histone deacetylase HDAC1, NuRD ATP-dependent chromatin remodeling 
complex and Polycomb group histone methyltransferase complex ESC-E(Z) (CZERMIN et al. 
2002; HASSIG et al. 1997; KUZMICHEV et al. 2002; XUE et al. 1998; ZHANG et al. 1998). 
Future studies will test these hypotheses and help elucidate how sophisticated networks 
regulate HIF during development, homeostasis and diseases. 
FIGURE LEGENDS 
Figure 1. The ia50;vhl-1(ok161) animals have egg-laying defects similar to those in egl-9 
loss-of-function mutants. (A-F). Representative images of Pnhr-57::GFP expression in wild 
type and mutant animals. Fluorescent images are paired with Nomarski images of the same 
animal. (A,D) wild type; (B,E) vhl-1(ok161); (C,F) vhl-1(ok161), ia50. (G, H) Representative 
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images of young adult wildtype (G) or vhl-1(ok161), ia50 animals (H) to illustrate the 
egg-laying defect. (I) Penetrance of egg-laying defect in vhl-1(ok161),ia50 mutants. (*** 
p<0.0001 compared to wild-type) (J) egl-9(sa307) and vhl-1(ok161),ia50 mutants have 
smaller brood sizes. (** p<0.01 compared to wild-type).  The vhl-1(ok161) and egl-9(sa307) 
alleles are strong loss-of-function alleles. 
Figure 2. ia50 is an allele of swan-1. (A) Genetic mapping of ia50. Three-point mapping 
with the indicated visible marker and single nucleotide polymorphisms placed ia50 to +5.67 
mu on chromosome V. Cosmids injected for transformation rescue are shown. DNA 
sequencing revealed a point mutation at the splicing acceptor of exon 3 of swan-1. This 
results in failed splicing of intron 2, which introduces an early stop codon. swan-1 encodes a 
WD40 repeat family protein. A schematic of the SWAN-1 protein and the position of the 
stop codon introduced by ia50 are shown. The region deleted by the ok267 allele is also 
illustrated. (B) RNAi of swan-1 increased Pnhr-57::GFP protein level. RNAi of swan-2 had 
no effect on Pnhr-57::GFP expression. 
 
Figure 3. SWAN-1 regulates HIF-1 activity in animals that do not destabilize HIF-1. 
(A-F) Expression of Pnhr-57::GFP and two HIF-1 target genes in wild-type and various 
mutants. Relative level of Pnhr-57::GFP was measured by immuno-blots. K10H10.2 and 
F22B5.4 mRNA levels were quantitated by real-time RT-PCR. Data were obtained from 
three independent experiments. * p<0.05 calculated by student t-test. (G) The level of 
transgenic HIF-1::HA protein were assayed in N2, swan-1(ok267), vhl-1(ok161), and 
swan-1(ok267);vhl-1(ok161) L4-stage worms. 
 
Figure 4. SWAN-1 interacts with EGL-9 (A) swan-1(ok267) did not change the 
Pnhr-57::GFP expression in egl-9(sa307) mutants. (B) Yeast harboring EGL-9 bait plasmids 
(across the top) without and with the SWAN-1 prey plasmid (see materials and methods). 
Yeast were grown on medium containing X-Gal to indicate lacZ activity and a positive 
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interaction (blue). Yeast harboring the bait plasmids or SWAN-1 alone were overgrown to 
ensure absence of lacZ activity. (C) GFP tagged SWAN-1 pulled down MBP tagged EGL-9. 
SWAN-1::GFP fusion protein or GFP protein were immuno-precipitated using worm lysate 
prepared from transgenic lines containing swan-1::gfp transgene or gfp transgene. The beads 
were then incubated with bacteria lysate expressing recombinant EGL-9-MBP protein. The 
input SWAN-1::GFP and GFP proteins were detected by anti-GFP antibody (right). 
Interacting proteins were fractionated by SDS-PAGE, western-blotted and probed with an 
anti-MBP antibody. Unincubated bacteria lysate was included as a control. 
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Table 1:  Analysis of double heterozygotes reveals a novel mutant allele ia50 that 
increases nhr-57:GFP expression 
allele phenotype in trans to rhy-1 (ok1402) phenotype in trans to egl-9(sa307) 
ia21 increased Pnhr-57::GFP expression wild type 
ia50 wild type wild type 
ia51 increased Pnhr-57::GFP expression wild type 
ia54 increased Pnhr-57::GFP expression wild type 
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Table 2: SNP primers, locations and band sizes. In each pair of primers, the left primer 
is listed first; all primer sequences are given 5' to 3'. The Table is modified from Davis 
et al. (DAVIS et al. 2005) 
Genetic 
Location 
Physical 
Location 
Clone 
N2 
digest 
CB4856 
digest 
Primers 
Wormbase 
Identifier 
I, -19 169, 017 F56C11 500 ATGCCAGTGATAAGGAACGG snp_F56C11  
   
354, 
146  TCACATCCCTTGTCGATGAA  
I, -12 1,905,969 Y71G12A TCGAAATCAGGGAAAAATTGA snp_Y71G12  
   
503, 72 
377, 126, 
72 ACGATTTTCGGGGAGTTTTT  
I, -6 2,818,973 W03D8 GTTTTCACTTTTGCCGGTGT pkP1052 
   
395, 
144 
538 
TGAAGGCGCATATACAGCAG  
I, -1 4,594,014 D1007 459, 41 AAAATATCAGGAAAGAGTTTCGG snp_D1007 [7] 
   
325, 
134, 41  TTTAAAGATTAAGGGTGGAGCG  
I, 5 10,722,146 B0205 494 ATCTGGCACCAAATATGAGTCG CE1-247 
    
365, 129 
AATCTCGATTTTCAAGGAGTGG  
I, 13 12,047,594 F58D5 445 TCCTGGATAATCCCCAAAAA snp_F58D5  
    
295, 151 
CCCTGCCATTGATCTTGTTT  
I, 14 12,729,812 T06G6 335, 78 TTGAAATCCCCTTTAAAATCCC uCE1-1361 
   
236, 99, 
78  ACACTGGGTACCTGACTCATGC  
I, 26 14,682,016 Y105E8B 474, 27 ATTATTAACGGCCACGGTGA snp_Y105E8B  
   
360, 
114, 27  CCCACACACTCTCACCTTCA  
II, -18 176,720 T01D1 375 CCGAATTTTCAAATGGATGC pkP2101 
   
263, 
112  CCATTGGAATTGCACACAAA  
II, -14 2,121,018 R52 345 CTGTGCTGTTGACGATATTGG snp_R52  
    
236, 109 
ATGTCTCATTGCAAAATTCGG  
II, -6 3,828,599 F54D10 516 TTGTGAGCTTATATCTCAGTTGTCG pkP2103 
    
387, 129 
AGATTTGGTTAGAAATATCACCGC  
II, 1 9,052,466 T24B8 494 TCAAAAACTTACAATCAATCGTCG snp_T24B8 
   
373, 
121  CCAGAAAATCTGCACAGAAGG  
II, 4 11,827,835 Y6D1A 
340, 124, 
44 
TTCTTCAAAAAGTCTAGGTTCAGCA snp_Y6D1 
   
224, 
117, 
124, 44  GGGGACGAAAACGGAGTTTG  
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Genetic 
Location 
Physical 
Location 
Clone 
N2 
digest 
CB4856 
digest 
Primers 
Wormbase 
Identifier 
II, 11 12,605,350 Y38E10A 483 ACCGTTTAATAGGATTATTTGGG uCE2-2131 
    
352, 132 
AAGTCTGCGGAATAATTGATGG  
II, 16 13,235,564 F15D4 500 TTCCAGGTAATACACATACAACTCC pkP2116 
    
368, 132 
AAAAACACAAAGTTCAAAAACCC  
II, 22 14,132,466 K09E4 484 CCACTGGCTATAAGCTTTTCTAGG CE2-215 
   
365, 
119  TAAGGATTTCAGGCTTTTAGGC  
III, -25 939,698 T12B5 395 TATCATCGAAATCCCGGAAA uCE3-637 
   
206, 
189  TTCGGACGGGAGTAGAATTG  
III, -19 1,827,732 Y39A3CL 
272, 78, 
76, 70 
TCCCAATTTCCCTCTAAAAACC uCE3-735 
   
342, 78, 
76 
 TTGAATTTGGACCATTTTGAGG  
III, -12 2,599,699 Y71H2B 473 GAGGAACCAAATCTGGCGTA snp_Y71H2B  
   
368, 
105  TGAAAACTTGGAAAATCGGTG  
III, -7 3,359,033 F45H7 
196, 85, 
43, 27 
AATTTGAATCAGTGACTTTTGGC CE3-127 
   
239, 85, 
27 
 TTTCTGCAAACATTTTTCTTCG  
III, -1 7,320,107 F56C9 486 AAAAATACATGTCTACACAACCCG snp_F56C9  
    
354, 132 
TTTCTTATCACTGTGCAGTCTTACC  
III, 4 10,652,476 Y39A1A 497, 30 AGCGTTAAAGTATCGGTTATTTCG snp_Y39A1 
   
355, 
142, 30  TAAATTCATTTCAAACAATCGAGC  
III, 12 11,656,188 Y41C4A 495 ATCAAGTTTCTGATTGCTCTTTCC snp_Y41C4 
   
339, 
156  AAAAACGTGATTTTTCAATTTTGC  
III, +21 13,715,622 W06F12 AGCAGGCTCACCATCATCATCA uCE3-1426 
   
273, 
137, 78 
200, 137, 
78, 73 GACATTACGGTAGAGGAGATGGA  
IV, -24 795,461 F56B3 429, 71 TGATGGTGTGTCTGCGTACC uCE4-515 
   
301, 
128, 71  AGAGCTGGAGAGCACGGATA  
IV, -16 1,799,032 Y38C1BA 491 CGCATAAATCCAACGTTCTCTG snp_Y38C1B 
   
187, 
304  AATCCATAAGTTTCGTGTTGGG  
IV, -7 2,761,525 Y54G2A 498 ACTCGGCATCCTCACGC snp_Y54G2 
    
250, 248 
GTTGAAAATTTTTTCATAGCTATCATC  
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Genetic 
Location 
Physical 
Location 
Clone 
N2 
digest 
CB4856 
digest 
Primers 
Wormbase 
Identifier 
IV, -5 3,347,952 F42A6 419 TGCTGAAATATTGGAAAATTGAGG pkP4055 
   
295, 
124  TTATATCGTCGAGGAGGTTAGAGG  
IV, 1 4,991,851 E03H12 376 300, 76 AAAATGGGAAGCGTACCAAA pkP4071 
     TGCTTGTAGCGTTTCCAAGA  
IV, 8 13,049,020 F49E11 390 GACACGACTTTAGAAACAACAGC snp_F49E11 
   
313, 77 
 TGGTATGGAGTCCCTATTTTGG  
IV, 12 14,566,396 Y57G11B TGTAAATACCCCACATTTCAAGC snp_Y57G11B  
   
284, 
162, 52* 
327, 119, 
52* AAATTTCCAATTGTTCAAAGCC pkP4095* 
IV, 14 16,085,085 Y105C5B 
319, 108, 
48 
TCGAATTGTTGTGTTTCTTTTGA pkP4099 
   
241, 
108, 78, 
48  TTCCAATTTTCTCGGTTTGG  
V, -17 1,773,464 F36H9 386, 87 TTTCGGAAAATTGCGACTGT pkP5076 
   
307, 87, 
79  CGCGTTTTGGAGAATTGTTT  
V, -13 2,726,662 C24B9 455 TCATCTGTTATTTCGTCTCTTGC uCE5-828 
   
288, 
167  CGGTAATAATATGCTTTGTGGG  
V, -5 4,550,757 Y61A9LA 454 GAGATTCTAGAGAAATGGACACCC snp_Y61A9L 
    
307, 147 
AAAAATCGACTACACCACTTTTAGC  
V, 1 7,089,411 VC5 AGAAATGATCCGATGAAAAAGC pkP5097 
   
435, 70 
300, 135, 
70 CCGATAGTGTTCATAGCATCCC  
V, 6 13,951,850 R10D12 500 CAAATTAAATATTTCTCAAAGTTTCGG  
    
348, 152 
ACATAAGCGCCATAACAAGTCG  
V, 6.42 14,486,292 R02D5   AGTATGACCTAGATGCGAAC pkP5086 
     TGGCTAAACTCGTGATTCTC  
V, 10 16,321,481 F57G8 TAAAGCCGCTACGGAAATACTC pkP5129 
   
475 288, 187 
ATTTTCTCCCTAATTCCAGGTG  
V, 13 17,610,508 Y6G8 487 CATTCATTTCACCTGTTGGTTG uCE5-2609 
   
282, 
205  TCGGGAAGATAATCAAAATTCG  
V, 18 18,782,547 Y17D7B 488 GAAATTCAAATTTTTGAGAAACCC snp_Y17D7B 
   
324, 
164  TTCAGACCATTTTTAGAATATTCAGG  
X, -17 2,065,464 F49H12 540 ATATGTGAGTTTACCATCACTGGG pkP6143 
    
321, 219 
ACGTTTTGAAAAATTTGGTTGC  
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Genetic 
Location 
Physical 
Location 
Clone 
N2 
digest 
CB4856 
digest 
Primers 
Wormbase 
Identifier 
X, -8 4,161,493 ZK470 
326, 96, 
72, 40 
CCAAAACGGCCAAGTATCAG pkP6105 
   
422, 72, 
40 
 TTGCACTCTTTCTCCTTCCG  
X, -4 5,934,688 C46F4 
223, 51, 
35, 22 
AAGTGTTCAATGATTTTGTCTAATTG uCE6-981 
   
169, 54, 
51, 35, 
22  TGACAGGAGAATACTTTTGAAGG  
X, 2 10,637,922 F11A1 542 AGCAACAAACAATGCAACTATGG snp_F11A1 
   
409, 
133  TAAACAAGAGGGTACAAGGTATCG  
X, 8 12,750,713 F22E10 467 TTAAAACCATACAATTCTTCTCAGC snp_F22E10  
   
341, 
126  GAATTCCCAATCAACAGAGAGC  
X, 11 13,339,566 F46G10 509, 37 ACTGTTTACCGCGTCTTCTGC pkP6132 
   
318, 
191, 37  CCGTGTATATAAGAAAATGTGTTCG  
X, 17 14,547,382 T24C2 GCTGGGATTTTGAAGAGTTGTT uCE6-1459 
   
409, 34 
302, 107, 
34 CAGTGAATCATCCGTTGAATTT  
X, 23 15,500,013 H13N06 
358, 
134 
492 CAAATACCAAAGTTGATCGTGG uCE6-1554 
     TTGTTGCAATTAAATCAAACGG  
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Figure 1. The ia50;vhl-1(ok161) animals have egg-laying defects similar to those in egl-9 
loss-of-function mutants. 
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Figure 2. ia50 is an allele of swan-1. 
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Figure 3. SWAN-1 regulates HIF-1 activity in animals that do not destabilize HIF-1. 
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Figure 4. SWAN-1 interacts with EGL-9 
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CHAPTER 6. GENERAL CONCLUSION 
SUMMARY 
Hypoxia-inducible factor (HIF) is the master regulator of transcriptional changes 
during hypoxia adaptation in C.elegans as wells as in humans. In this dissertation, I used the 
nematode C.elegans as a model to study the role of HIF-1 in organismal aging. Major 
findings include: 1) HIF-1 over-expression through extra copies of a hif-1 transgene can 
extend lifespan. This prolongevity effect is independent of daf-16/FOXO and skn-1/NRF 
transcription factors and may work downstream of the daf-2 insulin like growth factor 
receptor. 2) the hif-1 loss-of-function mutation also confers increased longevity at standard 
culture conditions. This longevity phenotype, unlike that of HIF-1 over-expression, is 
dependent on daf-16/FOXO and skn-1/NRF. 3) Both HIF-1 over-expression and hif-1 
loss-of-function mutations increase resistance to thermal stress and oxidative stress in 
C.elegans. 4) Hypoxia treatment extends lifespan in C. elegans. This longevity effect does 
not require functional HIF-1 signaling. Instead, IRE-1-mediated unfolded protein response 
pathway is required for hypoxia to extend lifespan. 
The second part of the thesis is devoted to understand the regulatory networks that 
control the HIF-1 activity. Using forward genetic approaches, I identified swan-1 as a novel 
negative regulator of HIF-1. Loss-of-function mutations in swan-1 increase HIF-1 
transcriptional activity in wildtype as well as vhl-1 mutant background..  However, 
loss-of-function mutations in swan-1 do not enhance the egl-9 mutant phenotype, as assayed 
by increased expression of HIF-1 target genes. The data further demonstrated that SWAN-1 
can physically interact with EGL-9. These results suggest a model in which SWAN-1 
regulates HIF-1 activity via an egl-9-mediated mechanism that functions in parallel to the 
oxygen-dependent degradation pathway of HIF-1.  
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GENERAL DISCUSSION 
HIF-1 modulates aging in C.elegans 
Aging is a basic biological process and perhaps one of the most important factors 
associated with the incidence of many age-related diseases, such as cancer, diabetes and 
neurodegenerative diseases. Understanding the mechanisms of aging will not only shed light 
on the fundamental questions in biology, but also provide insights to the treatment of 
age-related diseases. 
C. elegans, because of its powerful genetics and relatively short lifespan, has become 
an important model organism for the study of aging. Since the first discovery of the 
long-lived mutant worm in 1980s, hundreds of genes have been found to modulate aging in C. 
elegans (JOHNSON 2008). Among these genes, a handful of stress responsive transcription 
factors, including daf-16, skn-1, hsf-1 and pha-4, have been shown to be the critical 
regulators in the aging-regulation networks (HENDERSON and JOHNSON 2001; HSU et al. 2003; 
LIN et al. 2001; MORLEY and MORIMOTO 2004; PANOWSKI et al. 2007; TULLET et al. 2008). 
In Chapter 2, I showed evidence that hif-1 is another stress response transcription 
factor that play important roles in modulating aging in C.elegans. Over-expressing HIF-1 
through extra-copies of hif-1 transgene could extend life span to as much as 34% (Chapter 3 
Figure 2, Table 1). HIF-1 over-expression in daf-16 or skn-1 mutation background extended 
the life span of mutant worms to a similar degree (Chapter 2 Figure 3, Table 2), suggesting 
that the prolongevity effect of HIF-1 over-expression is independent of DAF-16 and SKN-1. 
Interestingly, I found hif-1 loss-of-function mutations could also increase longevity at least 
10% (Chapter 2 Figure 4). This longevity effect was completely abolished in daf-16 or skn-1 
mutants, suggesting that HIF-1 over-expression and hif-1 loss-of-function may extend life 
span through distinct mechanisms. 
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Does HIF-1 over-expression modulate aging cell autonomously or 
systematically? 
The genetic data in Chapter 2 leave open the possibility that hif-1 is in the 
downstream of daf-2 to regulate aging. However, the daf-2(1370) mutation did not cause a 
significant change in HIF-1 protein levels, or in the expression of HIF-1 target genes, as 
assayed by western-blot or qRT-PCR (Chapter 2, Figure 5). One explanation for this 
observation is that DAF-2 may regulate HIF-1 in specific cells or tissues to modulate aging. 
Indeed, prior studies have demonstrated that stress-responsive transcription factors can have 
non-cell-autonomous roles in organismal aging. For example, intestine-specific expression of 
DAF-16 completely restored the longevity of daf-16 deficient animals (LIBINA et al. 2003). 
Over-expressing SKN-1 in two neurons was shown to be sufficient to extend lifespan in C. 
elegans (BISHOP and GUARENTE 2007). Studies from Pocock and Hobert (POCOCK and 
HOBERT 2008) and Hoogewijs et al (HOOGEWIJS et al. 2007) suggested that DAF-16 
modulates HIF-1 levels in some conditions or cell types. To define the sites where HIF-1 
regulates lifespan extension in C. elegans, we can generate transgenic animals that express 
the hif-1 transgene in specific tissues. The lifespan and stress resistance assay of these 
transgenic animals will tell us whether HIF-1 controls downstream genes in specific 
responding cells to modulate aging. 
A recent study from Chen et al showed that HIF-1 functions in specific neurons and 
muscles to modulate Dietary Restriction (DR) dependent lifespan extension (CHEN et al. 
2009). In their study, loss-of-function mutation of hif-1 was found to extend lifespan in a 
nutrient-dependent manner. hif-1 loss-of-function mutant lived longer in rich nutrient 
condition but failed to extend lifespan under DR. Loss-of-function mutation of egl-9, which 
increased HIF-1 expression, abolished longevity effect of DR. Using transgenic animals that 
express egl-9 in various tissues under egl-9 mutant background, these authors found that 
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egl-9 expression in body wall muscle and serotonergic neurons was important for 
HIF-1-mediated lifespan extension via DR. In addition, a recent study from Chang et al 
(CHANG and BARGMANN 2008) demonstrated that HIF-1 functions both in neurons and gonad 
endocrine cells to regulate oxygen preference in C. elegans. We predict that over-expression 
of HIF-1 acts in multiple tissues to modulate lifespan. 
Which genes regulated by HIF-1 are important for life span extension? 
HIF-1 regulates the transcriptional changes of a wide range of genes for organisms to 
adapt to hypoxic conditions. Prior studies in our lab have identified 63 genes that are 
regulated by hypoxia in a hif-1 dependent manner (SHEN et al. 2005). It is conceivable that 
some of them may play important roles in regulating aging. Of particular interest are those 
genes involved in signal transduction, metabolism, transcription and stress responses.  In 
future studies, it would be interesting to use RNAi to knockdown these genes to test whether 
they are required for HIF-1 over-expression mediated life span extension. 
There are several potential caveats, however, in referencing the previous genome- 
wide microarray study. First, as discussed above, HIF-1 may regulate gene expression in 
specific cells or tissues to extend life span. Some hif-1 regulated genes that are important for 
aging-regulation may not be reflected in samples prepared from whole animals. Second, my 
studies in Chapter 3 indicated that HIF-1 over-expression induced by hypoxia during larval 
development is insufficient to extend life span (Chapter 3 Figure 1C). It is worth noting that 
the samples used in previous microarray study were prepared from L3 larvae, which may not 
correctly reflect the transcriptional changes associated with adult life span extension. 
Towards the goal of identifying HIF-1 targets that modulate adult longevity, future studies 
could analyze the gene expression patterns of long-lived animals that over-express HIF-1. 
The result may be more informative in evaluating which genes might be involved in the 
prolongevity effects of HIF-1 over-expression. 
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Hypoxia modulates aging in C. elegans 
After establishing HIF-1 as an important transcription factor that modulates aging in 
C. elegans, one intriguing question to ask is whether hypoxia influences longevity. In my 
PhD study, I found that hypoxia extended the adult life span of C.elegans by around 20% 
(Chapter 3 Figure 1, Table1). I also showed that hypoxia treatment during the adult stage 
conferred longevity in hif-1 loss-of function mutants as well as HIF-1 over-expression 
transgenic worms (Chapter 3 Figure 2, Table1). These results suggested that hif-1 is not the 
only signaling pathway that regulates hypoxia-mediated longevity in C.elegans. I further 
demonstrated that hypoxia can extend life span via mechanisms independent of the daf-2 
insulin like growth factor pathway (Chapter 3 Figure 3, Table 1). I presented evidence that 
IRE-1 mediated ER stress response is induced by hypoxia and is required for hypoxia 
mediated longevity effect (Chapter 3 Figure 4 and 5).  
The biological significance of hypoxia 
Hypoxia is important to many biological processes, including development, 
regeneration and animal hibernation, and is associated with a number of diseases, such as 
stroke, ischemia and cancer. Hypoxia tolerance varies between species and cell types, and is 
a major determinant in many pathological conditions. For example, hypoxia in stroke and 
ischemia can cause neuronal dysfunction and cell death, while tumor hypoxia is relevant to 
resistance to chemotherapy and radio-therapy (BERTOUT et al. 2008). In my study, hypoxia 
treatment delays aging and increases thermotolerance and oxidative stress resistance. On the 
other hand, severe hypoxia (<0.3%) at high temperatures (26oC) can result in hypoxic injury 
and worm death (SCOTT et al. 2002). Understanding the roles of hypoxic response signaling 
in different hypoxia conditions may help us to develop novel therapies for hypoxia-related 
diseases. 
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Multiple signaling pathways regulate hypoxia mediated longevity 
HIF-1 regulates most of the transcriptional changes that enable organisms to adapt to 
hypoxia.  A previous microarray study in our lab has revealed that transcriptional 
expression of some genes, including daf-16, is regulated by hypoxia in a hif-1-independent 
manner (SHEN et al. 2005). The data that hypoxia can extend life span of hif-1 and daf-16 
deficient animals suggest that metabolic changes responding to hypoxia are mediated by 
multiple signaling pathways. In my study, ER stress response pathway is clearly involved in 
hypoxia mediated longevity. However, whether induced ER stress response is sufficient to 
extend life span or just required for hypoxia tolerance still remains unclear.  
There are at least two models to explain the requirement of ire-1 in hypoxia-induced 
lifespan extension. First, UPR components might be induced by hypoxia and act in parallel to 
HIF-1 to extend adult longevity.  Alternatively, animals that are defective for UPR 
components may suffer more from hypoxic stress, offsetting the benefits of hypoxia.  To 
help distinguish between these possibilities, future studies could test the hypothesis that 
over-expression of UPR components have prolongevity effects.   
When considering alternative models, it is important to recall that C. elegans prefer 
oxygen levels in the range of 5 – 14% (CHANG and BARGMANN 2008).  Room air is, 
therefore, hyperoxic.  It is possible that hyperoxia suppresses longevity and that removing 
worms from hyperoxia (to 5% or 1% oxygen) results in less proteotoxicity and longer life, 
provided the UPR is intact. To test this hypothesis, we may assay lifespan of worms under 
5% and 10% oxygen, and determine whether the change of lifespan, if any, depends on 
functional UPR.  
A recent study from Chen et al (CHEN et al. 2009) showed that ire-1 mutation 
significantly reduces the longevity effect of DR. ire-1 mutation completely suppressed the 
lifespan extension by hif-1 loss-of-function mutation in rich nutrient condition. These results 
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and ours suggested that functional UPR is required for multiple signaling pathways in 
modulating lifespan. 
My work opens the door to new questions about hypoxia and aging.  It will be 
important to identify the genes and pathways that mediate the hif-1-independent effects of 
hypoxia.  It would be informative to compare the gene expression patterns of 
hypoxia-treated wild-type or hif-1-deficient adults with those of adult animals 
over-expressing HIF-1. To study the hif-1-independent signaling pathways involved in 
hypoxia mediated longevity, we can use gene expression analysis to identify the changes of 
gene expression after hypoxia treatment in adult stage. The results can then be compared 
with those genes regulated by HIF-1 over-expression in hif-1 trangenic worms (as discussed 
above) to measure which genes may modulate longevity in parallel with hif-1. 
The transcriptional induction of gene expression is a major mechanism in hypoxia 
adaptation (WENGER 2000). However, transcriptional changes are not the only responses that 
help organisms to adapt to hypoxia. In mammalian cells, hypoxia can suppress mRNA 
translation by activating UPR (WOUTERS and KORITZINSKY 2008). Abundant results have 
shown that protein homeostasis plays important roles in modulating aging (HANSEN et al. 
2007; PAN et al. 2007a; SYNTICHAKI et al. 2007). Recently, Anderson et al. showed that 
depletion of an arginyl-transfer RNA (tRNA) synthetase results in increased resistance to 
high-temperature hypoxia treatment. This hypoxia resistance phenotype required functional 
UPR, suggesting that the role of UPR in suppressing translation may be conserved in 
C.elegans (ANDERSON et al. 2009). Therefore, an intriguing model is that hypoxia may 
extend lifespan in C.elegans by decreasing translation rate through UPR. 
Oxygen deprivation of mammalian cells also represses mRNA translation by 
inhibiting the TOR (Target of Rapamycin) pathway (WOUTERS and KORITZINSKY 2008). In 
C. elegans, inhibition of the TOR pathway extends lifespan and produces autophagy 
(HANSEN et al. 2008; JIA et al. 2004; VELLAI et al. 2003). Recent studies suggested that TOR 
signaling pathway plays important role in DR-dependent lifespan extension (CHEN et al. 
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2009; HONJOH et al. 2009; SHEAFFER et al. 2008)Hence, it is worthwhile to test whether 
hypoxia can also inhibit TOR pathway in C. elegans, and whether the inhibited TOR activity 
accounts for the life span extension induced by hypoxia. 
 
SWAN-1 regulates HIF-1 in C.elegans 
Using a visual assay based genetic screen, prior lab mates have isolated an array of 
mutant alleles that increase the expression of a HIF-1 target gene (SHEN et al. 2006). In 
Chapter 5, I Showed that some of these mutations mapped to rhy-1, and one identified a 
novel regulator of HIF-1. The ia50 mutant allele was mapped to swan-1(F53C11.8), which 
encodes a WD repeat protein.  The ia50 allele harbors a G to A conversion at the splicing 
acceptor site of intron 2.  This results in a mis-spliced mRNA that includes an early stop 
codon and may encode a truncated protein with only 2 of the 8 WD motifs. This molecular 
characterization and additional genetic analyses show that is50 is likely a loss-of-function 
mutation of swan-1. My genetic data suggest that SWAN-1 regulates HIF-1 via a mechanism 
distinct from the VHL-1 mediated degradation pathway: 1) the HIF-1 dependent 
Pnhr-57:GFP reporter is expressed in distinct patterns and different levels in swan-1 mutants 
and vhl-1 deficient animals (Chapter 4 Figure 1); 2) HIF-1 protein levels do not change in 
swan-1 deficient worms, while the vhl-1 mutation causes around 3-5 fold increase in HIF-1 
protein levels (Chapter 4 Figure 3) (SHAO et al. 2009; SHEN et al. 2006); 3) Worms that carry 
loss-of-function mutations in both swan-1 and vhl-1 express significantly higher levels of 
HIF-1 target genes compared with each single loss-of-function mutant (Chapter 4 Figure 3). 
The dual functions of EGL-9 
EGL-9 is the enzyme that catalyzes the hydroxylation of HIF-1, which allows its degradation 
in normoxia (EPSTEIN et al. 2001). Hence, EGL-9 clearly serves as an oxygen sensor in 
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regulating HIF-1 stability. Prior studies indicate that in addition to its role in controlling 
HIF-1 protein level, EGL-9 also inhibits HIF-1 transcriptional activity (SHEN et al. 2006). 
Other members in our group has tested this hypothesis rigorously and shown that the function 
of EGL-9 in attenuating HIF-1 transcriptional activity did not require its enzymatic activity 
of hydroxylation (SHAO et al. 2009). However, the molecular basis of this inhibition is still 
unclear. My findings that swan-1 mutation failed to increase HIF-1 activity in egl-9 mutant 
background and that SWAN-1 interacted with EGL-9 physically both support a model in 
which EGL-9 inhibits HIF-1 activity at least in part through interacting with SWAN-1. 
How does swan-1 regulate HIF-1 activity? 
WD-repeat proteins form a large family with diverse functions. Many WD-repeat 
proteins have been found to serve as a platform to facilitate formation of large protein 
complexes (LI and ROBERTS 2001). SWAN-1 was first identified in a yeast two-hybrid 
screen searching for the proteins interact with the Rac GTPase effector UNC-115/abLIM 
(YANG et al. 2006). Further studies indicated that SWAN-1 also interacted with Rac GTPase 
(Rac-2) and inhibited Rac GTPase function in cell morphogenesis and cytoskeletal 
organization (YANG et al. 2006). Our data that SWAN-1 physically interacted with EGL-9 
indicated that SWAN-1 may participate in multiple pathways through binding with its 
partners.  
Previous experiments using the SWAN-1::GFP transgene suggested that SWAN-1 is 
expressed in most of the cells except the intestine and that it predominantly locates in the 
cytoplasm. Intriguingly, in vhl-1 loss-of-function mutant, HIF-1 reporter Pnhr-57::GFP 
expresses predominantly in intestine. swan-1, vhl-1 double mutant has a broader expression 
pattern of Pnhr-57::GFP. It is enticing to speculate that SWAN-1 might form a complex with 
HIF-1 and sequester HIF-1 from localizing to nucleus. To this end, co-immuno precipitation 
(co-IP) experiment using SWAN-1::GFP transgene can not detect the interaction between 
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SWAN-1 and HIF-1. However, it is possible that their interaction is limited in specific tissue 
or not strong enough to be measured by our assay.  
Another attractive model of how SWAN-1 regulates HIF-1 is that SWAN-1 may 
repress the expression of HIF-1 target genes. Many WD-repeat proteins have been found to 
involve in chromatin remodeling and gene regulation (SUGANUMA et al. 2008b). One 
approach to test this hypothesis is to use chromatin immunoprecipitation (CHIP) assay to 
measure whether SWAN-1 resides in the vicinity of HIF-1 target genes on chromosomes.  
 Further studies of SWAN-1 may shed light on some of the key questions in HIF-1 
signaling.  How does EGL-9 repress HIF-1 activity?  Is HIF-1 differentially regulated by 
VHL-1, EGL-9, or SWAN-1 in different tissues?  Do SWAN-1, EGL-9, and RHY-1 act 
through a common pathway to repress the expression of HIF-1 target genes, or do they act in 
parallel?  Which of these regulatory mechanisms are evolutionarily conserved?  Screens 
for SWAN-1-interacting proteins and novel screens for genes mutable to the vhl-1, swan-1 
double mutant phenotype are promising approaches to these important questions. 
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Appendix I. Co-immunoprecipitation of HIF-1 interacting 
proteins from Caenorhabditis elegans 
Hypoxia inducible factor (HIF) transcription factor is the master regulator that 
mediates most of the transcriptional changes that enable adaptation to oxygen deprivation. 
The heterodimeric HIF complex consists of two subunits, both of which can interact with 
DNA and contain bHLH and PAS domains. The complex binds DNA in a sequence-specific 
manner [Note: the monomers do not]. While HIFβ interacts with other bHLH-PAS proteins, 
HIFα subunit is acutely regulated by cellular oxygen levels and is dedicated to oxygen 
homeostasis. The stability of the HIF α subunit is regulated by the EGLN/pVHL pathway: 
when cellular oxygen is high enough, HIF-α is hydroxylated by EGLN enzymes, which are 
2-oxoglutarate dioxygenases. This modification in turn allows HIF-α to be recognized by 
pVHL, an ubiquitin E3 ligase, which poly ubiquitinates HIF α and targets it for proteosomal 
degradation. This oxygen-dependent degradation pathway is conserved in humans and C. 
elegans. The orthologs of HIF-α, HIF-β, EGLN and VHL in C. elegans are hif-1, aha-1, 
egl-9 and vhl-1, respectively (EPSTEIN et al. 2001; JIANG et al. 2001; POWELL-COFFMAN et al. 
1998). 
Our prior studies support a model in which EGL-9 has two functions (SHAO et al. 2009; 
SHEN et al. 2006). First, EGL-9 hydroxylates HIF-1 in an oxygen-dependent manner which 
enables HIF-1 to bind VHL-1 and be degraded in normoxia. Second, EGL-9 inhibits the 
expression of HIF-1 target genes by an unknown mechanism that does not require EGL-9 
hydroxylase activity and does not involve VHL-1. 
How might EGL-9 repress expression of HIF-1 target genes? One possibility is that 
EGL-9 is present in a complex of HIF together with some transcription repressors. Indeed, it 
was proposed that in mammalian cells EGLN1 could recruit the ING4 transcription repressor 
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to the promoter of HIF target genes (OZER and BRUICK 2005). Alternatively, EGL-9 might be 
involved in some other modifications of HIF-1 that regulate its localization or activity. It is 
also possible that EGL-9 might have other substrate(s) that in turn attenuates HIF-1 activity. 
In order to gain insight to HIF-1 regulation and function, I attempted to define HIF-1 
complexes through co-immunoprecipitation (co-IP). 
In order to identify the HIF-1 associating proteins with co-immunoprecipitation (co-IP), 
I first generated a construct in which an epitope tag was fused to hif-1 (Figure 1 A and also 
described in Chapter 2). Additional constructs and strains are listed in Table 1. The original 
design of this epitope enabled the tandem affinity purification of HIF complexes through 
myc, strep and HA tags. However, pilot experiments demonstrated that the binding efficacy 
of HA or strep tags were too low to be used in purification (data no shown). Therefore, I 
opted for one step purification in which I used the myc tag to immunoprecipitate transgenic 
HIF-1 protein, followed by tobacco etch virus (TEV) protease digestion to release the HIF-1 
complex from the beads. 
The epitope tagged hif-1 construct was inserted into the genome of the worms by 
gold-particle bombardment (PRAITIS et al. 2001). Stable transgenic lines carrying 
epitope-tagged hif-1 were crossed to vhl-1(ok161) or egl-9(sa307) mutant backgrounds and 
the HIF-1 protein levels were assayed by western-blot. In agreement with the result of 
endogenous HIF-1, vhl-1(ok161) or egl-9(sa307) mutations increased epitope-tagged HIF-1 
levels by about 4-fold (EPSTEIN et al. 2001; SHEN et al. 2006) (Figure 1 B). The activity of 
HIF-1 was also measured by detecting the expression of a HIF-1-regulated GFP reporter 
gene (SHEN et al. 2006). Epitope-tagged HIF-1 rescued the expression of the Pnhr-57:GFP 
reporter in a strain carrying a deletion in the endogenous hif-1 gene (Figure 2). Moreover, we 
found that the egl-9(sa307) mutation had a much greater effect on the expression of 
Pnhr-57:GFP than did the vhl-1(ok161) mutation. This confirmed that HIF-1:myc was 
regulated by both the VHL-1/EGL-9 pathway for degradation and the VHL-1-independent 
pathway by which EGL-9 represses HIF-1 activity. 
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Using this transgenic strain, I did some pilot co-immunoprecipitation experiments to 
test whether the HIF complex could bind to the myc antibody coupled sepharose beads and 
then be released by protease digestion. Indeed, endogenous AHA-1 was co- 
immunoprecipitated and also released after protease digestion together with epitope-tagged 
HIF-1, which indicated that at least the prototypic HIF complex was preserved in the assay 
(Figure 1 C). 
To generate sufficient starting materials for co-IP, I optimized large-scale production 
of nematode transgenic lines using enriched peptone plates (1.2g NaCl, 20g peptone, 25g 
agar in 1L water. Autoclave. Cool to 55ºC, then add 1ml of 5mg/ml cholesterol, 1ml of 1M 
MgSO4 and 25ml of 1M potassium phosphate, pH 6.0) spotted with NA22 bacteria lawn. The 
transgenic line was grown at 20ºC on 4 100mm enriched peptone plates until most of the 
worms were starved L1 larvae. The worms were then washed off the plates using cold M9 
buffer and aliquotted onto 40 100mm enriched peptone plates. Two days later, the worms 
were harvested using cold M9 buffer and centrifugation at 2000× g. Typically, 10 grams of 
worms (around 10 ml worm pellet) could be collected from 40 100mm plates. The worm 
pellet was washed twice in cold M9 buffer and then resuspended in 40 ml lysis buffer [100 
mM PIPES, pH 6.0, 100 mM NaCl, 3 mM MgCl2, 1 mM EGTA, a mM dithiothreitol (DTT), 
1 mM phenylmethylsulfonyl fluoride (PMSF), 0.5% Triton X-100, Complete Protease 
Inhibitor Tablets (Roche), and phosphatase inhibitors (5 mM NaF and 1 mM Na3VO4)]. The 
mixture could then be frozen down in 10 ml aliquots in liquid nitrogen and stored at -80ºC.  
To generate whole worm extracts, a single freeze/thaw cycle was performed before 
the suspension was lysed by passing through a French Press cell disrupter (Thermo Electron 
Corporation) at 8000 psi three times (Albertha et al., 2006). The mixture was clarified by 
centrifugation at 16000× g for 20 minutes at 4ºC and the soluble supernatant fraction was 
collected. 
To prepare Mab9E10 (myc)-coupled protein G beads, 1 mL of sepharose Protein G 
Beads (ZYMED laboratories) (sepharose beads show less non-specific binding compared to 
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agarose beads) was incubated at 20ºC with mouse ascite (2 mg of protein, from 
Developmental Studies Hybridoma Bank) for 2 hours, and washed with 10 volumes of 0.2 M 
sodium borate, pH 9.0. Antibody bead coupling was performed by adding 2mM 
dimethylpimelimidate dihydrochloride at 20ºC for 30 min (POLANOWSKA et al. 2004). The 
coupling reaction was stopped by washing with 5 volumnes of 0.1 M Tris-HCl, pH 8.0, and 
10 volumnes of phosphate buffered saline (PBS). The coupled beads were stored at 4ºC in 
two volumes of PBS with 0.5% sodium azide. Prior to co-IP, the beads were washed with 
Binding buffer (50 mM Tris-HCl, pH 7.3, 0.1 M KCl, 1mM EDTA and 10% glycerol). 
To perform co-IP, worm lysate prepared from each transgenic line was incubated 
with c-myc antibody coupled sepharose beads at 50 uL of beads per mL extract. ProteinG- 
sepharose beads without coupling of myc antibody, where most of the none-specific binding 
came from, were used as controls. The absorption was done at 4ºC for 6 h. The beads were 
then washed with binding buffer 5 times before they were aliquotted to separate tubes at 100 
uL slurry (about 50 uL beads) per tube. The cleavage reaction was performed by adding 2 uL 
0.1 M DTT and 2 uL AcTEV (10U/uL) (Invitrogen) to each tube and incubated at 4ºC 
overnight with gentle shaking (for some unknown reason, I found digestion result was much 
better in small reaction volume). The slurry was then transferred to a Micro bio-spin column 
(Bio-rad). The elution was collected by low speed centrifugation. 
The proteins eluted from protease digestion were concentrated by Trichloroacetic 
Acid (TCA) precipitation. One fifth volume of 100% TCA and 10 ug insulin (Sigma, 5 ug/uL 
in H2O) (to help precipitate low amount of proteins, optional) was added to elution and 
incubated on ice for 30 minutes. The precipitation was harvested by centrifugation at 
16000× g and washed with 300 uL cold acetone. The precipitation was then vacuumed dry 
and dissolved in 10 uL 1M Tris-HCL (pH8.0) and 10 uL 2×SDS-PAGE buffer [100mM 
Tris-HCl pH6.8, 20%(v/v) glycerol, 4% (w/v) SDS, 200mM DTT, 0.2% (w/v) bromphenol 
blue]. The sample was resolved on 10% SDS-PAGE gel and stained with Novex Colloidal 
Blue Staining Kit (Invitrogen). Bands were then excised from the gel and subjected to 
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LS-MS/MS Mass spectrometry analysis by TSQ Vantage Triple Quadrupole mass 
spectrometer (Thermo Scientific) at UC Davis Proteomic Core Facility.  
To this end, several candidate proteins have been identified from one experiment 
(Table 2). The results from the proteomic analysis need to be confirmed by genetic and 
biochemical experiments to reveal the biological significance of the interaction.  
Collaborating with Mark Roth’s research group, we have generated a monoclonal 
antibody against HIF-1. This antibody provides opportunity to immunoprecipitate the 
endogenous HIF-1 complex. One potential caveat of this approach is that monoclonal 
antibody may recognize the epitope that interacts with HIF-1 associated proteins and thereby 
fail to immunoprecipitate the HIF-1 complex. Another concern is that IgG protein will 
impose a heavy background due to the lack of method to release HIF-1 complex off the beads. 
Nevertheless, HIF-1 monoclonal antibody can be used in co-IP experiments to confirm the 
results from our proteomic analysis. Similarly, the AHA monoclonal antibody could be used 
to IP the HIF-1 transcription complex, and interacting proteins in a wild-type animal could be 
compared to those in a hif-1 mutant. 
 
FIGURE LEGENDS 
Figure 1. Identify HIF-1 interacting proteins through co-immunoprecipitation. (A) 
Diagram of the epitope-tagged hif-1. Detailed diagram of epitope tag is also illustrated. (B) 
epitope-tagged HIF-1 transgene is functional in vivo. Western-blot comparison of the 
vhl-1(ok161) and egl-9(sa307) phenotypes in hif-1(ia04) mutant background indicates that 
HIF-1::myc is appropriately regulated by these genes: both mutations increase HIF-1::myc 
protein to similar levels but the egl-9(sa307) mutation derepresses expression of the 
Pnhr-57::GFP reporter to a much higher level. (C) Western-blot shows a result of a co-IP 
experiment of HIF-1 associating proteins with c-myc antibody coupled sepharose beads. 
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Lysate prepared from vhl-1(ok161) worms carrying the Phif-1::hif-1::tag transgene was 
loaded on c-myc antibody coupled sepharose beads. The HIF complex binding to the beads 
was released using AcTEV protease digestion. AHA-1, the partner of HIF-1, was present in 
the elution while TUBULIN was absent. AHA-1 was detected by mouse monoclonal 
antibody 10H8 (JIANG et al. 2001); α-TUBULIN was detected by mouse monoclonal 
antibody clone DM1A (Sigma). (D) Elutions from co-IP experiments was concentrated by 
TCA and resolved on 10% PAGE gel. After coomassie-blue staining, bands specifically 
appeared on transgenic line were excised and subject to MALDI-Mass Spectrometry analysis. 
One band was identified as RFP-1. 
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Table 1: Epitope-tagged HIF-1 transgenes. 
Plasmid 
name 
Description Epitope tag Original 
strains 
Reference 
pFOX1 Phif-1::hif-1a 6×myc ZG417 Zhang et al., 2009 
pFOX4 Phif-1::hif-1a (P621G) 6×myc ZG550, ZG552 
ZG554, ZG556 
Zhang et al., 2009 
pFOX5 Phif-1::hif-1a (∆ODD) 6×myc ZG436, 
ZG440, ZG441 
 
pFOX6 Phif-1::hif-1a HA+6×myc+strep ZG429 Zhang et al., 2009 
pFOX8 Phif-1::hif-1(genomic) HA+6×myc+strep ZG584, ZG590  
pFOX11 Phif-1::hif-1b HA+6×myc+strep ZG566, ZG567  
 
Table 2. Mass-spec results. 
 
 
Gene Name Gene ID M.W. Probability 
cyp-13A7(cytochrome P450 homolog) T10B9.10 59 98% 
hlh-11 F58A4.7a 46 90% 
teg-1(tumorous Enhancer of glp-1) 
uncharacterized, protein-protein interaction 
Y47D3A.27 42 85% 
hgo-1(Homogentisate Oxygenase W06D4.1 49 75% 
acs-18 (fatty acid CoA synthetase familgy) R09E10.3 79 72% 
crn-3 (cell death related nuclease) C14A.4 68 71% 
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APPENDIX II. ADDITIONAL RESULTS 
Does HIF-1 over-expression regulate mitochondria to extend lifespan? 
In Chapter3, I demonstrated that over-expression of HIF-1 protein can extend lifespan 
in C. elegans. However, the mechanisms behind this longevity effect remained unknown. 
Given that hypoxia-inducible transcription factors mediate a critical cellular metabolic 
adaptation to hypoxia, it is conceivable that a similar metabolic change activated by HIF-1 
may contribute to the lifespan extension. 
Studies from Dang and Denko groups demonstrated that in mammalian cells, HIF1 
actively suppresses aerobic metabolism through the tricarboxylic acid cycle (TCA) by 
directly trans-activating the gene pyruvate dehydrogenase kinase 1 (PDK1) (KIM et al. 2006; 
PAPANDREOU et al. 2006). PDK1 phosphorylates and inhibits pyruvate dehydrogenase (PDH), 
which converts pyruvate to acetyl-CoA and fuel the mitochondrial TCA cycle. The inhibition 
of TCA cycle and sequentially oxidative phosphorylation results in attenuation of reactive 
oxygen species (ROS) generation (KIM et al. 2006). If this pathway is conserved in C. 
elegans, it may account for the lifespan extension mediated by HIF-1 over-expression by 
decreasing ROS production.  
Indeed, one homolog of PDK, pdhk-2 (ZK370.5), is identified in C. elegans. 
Down-regulating pdhk-2 by RNAi abrogated the longevity effect of HIF-1 over-expression 
(Figure 1, Table 1). To test the hypothesis that HIF-1 over-expression suppressed PDK 
phosphorylation, I employed an antibody (Novus Biological) that recognizes phosphorylated 
PDH to measure the phosphorylation level of PDH. My results showed that phosphorylation 
of PDH actually decreased in HIF-1 over-expressing worms (Figure 1 B). These results 
indicate that HIF-1 over-expression may alter the mitochondrial metabolism in C.elegans. 
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However, relationship between the mitochondrial metabolic change and lifespan extension is 
complicated.  
 
hif-1 is involved in SIR2 pathway to modulate aging in C. elegans. 
SIR2 was first identified in yeast as a heterochromatin component that is associated 
with gene silencing at mating loci and telomeres (IVY et al. 1986). The proteins encoded by 
yeast SIR2 and its orthologs form a NAD-dependent protein deacetylase family that mediates 
the chromatin silencing (BLANDER and GUARENTE 2004; BRACHMANN et al. 1995; IMAI et al. 
2000). SIR2 genes have been shown to modulate aging in Saccharomyces cerevisiae, 
C.elegans and Drosophila melanogaster (KAEBERLEIN et al. 1999; ROGINA and HELFAND 
2004; TISSENBAUM and GUARENTE 2001). Transgenic worms carrying extra copies of sir-2.1 
live longer. This longevity effect of SIR2 over-expression is daf-16 dependent(TISSENBAUM 
and GUARENTE 2001). It has been proposed that SIR-2.1 interacts with 14-3-3 protein to 
regulate the nuclear localization of DAF-16 upon stress (BERDICHEVSKY et al. 2006; WANG 
et al. 2006).  
To test whether hif-1 is involved in life span extension mediated by SIR2 
over-expression, I assayed the life span of hif-1(ia04);sir-2.1(geIn3) and 
vhl-1(ok161);sir-2.1(geIn3) worms (geIn3 represents the chromosome integration of multiple 
copies of sir-2.1 transgene). I found that hif-1(ia04) suppressed the pro-longevity effect of 
sir-2.1(geIn3) while vhl-1(ok161) mutation further extended the life-span of long-lived 
sir-2.1(geIn3) worms (Figure 2, Table 2). These results suggest that hif-1 is required for 
sir-2.1-mediated life span extension. 
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A role of autophagy in lifespan extension mediated by HIF-1 over- 
expression and hypoxia. 
Autophagy is a process in which a cell degrades and recycles macro-molecules and 
organelles for energy and building blocks. During autophagy, portions of the cytoplasm are 
wrapped in double-membrane vesicles, called autophagosomes, which then fuse with 
lysosomes to degrade their contents. The degraded products are subsequently recycled to the 
cytoplasm (LEVINE and KLIONSKY 2004). 
Recent studies have demonstrated that autophagy plays important roles in life span regulation 
(TOTH et al. 2008). Inhibiting autophagy by RNA interference (RNAi) of bec-1, which is 
critical for initiation of autophagosome, suppressed the longevity phenotype of daf-2 mutant 
worms (MELENDEZ et al. 2003). Dietary restriction also required functional autophagy to 
extend lifespan in C.elegans (HANSEN et al. 2008; JIA and LEVINE 2007).  
Hypoxia has been shown to be one of the strongest signals to trigger autophagy. In 
mammalian cells, increased HIF-1 induces autophagy through . Recent study  
We tested the hypothesis that autophagy is involved in the lifespan extension 
mediated by HIF-1 over-expression and hypoxia. As shown in Figure 3B and Table 3, 
down-regulating bec-1 by RNAi suppressed life span extension mediated by HIF-1 
over-expression. Similarly, inhibiting autophagy by bec-1 RNAi abrogates the pro-longevity 
effect of hypoxia (Figure 3D, Table 4). These results demonstrated that autophagy is required 
for HIF-1 over-expression as well as hypoxia mediated life span extension. 
 
Figure Legends 
Figure 1. pdhk-2 is involved in lifespan extension mediated by HIF-1 over- expression. 
(A)RNA interference of pdhk-2, a homolog of pyruvate dehydrogenase kinase (PDK), 
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suppresses longevity effect of HIF-1 over-expression. (B) The level of phosphorylated 
pyruvate dehydrogenase (PDH) decreases in HIF-1 over-expression worms. 
 
Figure 2. hif-1 is involved in SIR2 pathway to extend the lifespan in C.elegans. hif-1(ia04) 
suppresses the long-lived phenotype of sir-2.1 over-expression worms while vhl-1(ok161) 
mutation further extends the life span of sir-2.1 over-expression worms. The proportion of 
animals alive is plotted against adult age. Lifespan values are given in Table1; assays were 
carried out at 20ºC. 
 
Figure 3. Autophagy is required for lifespan extension mediated by HIF-1 
over-expression and hypoxia. (A, B) bec-1 RNAi suppresses long-lived phenotype of HIF-1 
over-expression worms. (C, D) bec-1 RNAi suppresses pro-longevity effect of hypoxia. The 
proportion of animals alive is plotted against adult age. Lifespan values are given in Table1; 
lifespan assays of HIF-1 over-expression were carried out at 20ºC. Hypoxia lifespan assays 
were carried out at 25ºC. 
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Table 1: Effects of pdhk-1 RNAi on the longevity of wildtype and HIF-1 
over-expression worms. 
strain 
Adult life span 
mean +S.E. 
Maximum 
lifespan 
Percentage 
v. control  n p† value 
N2 (L4440 RNAi) 17.1 ± 0.6 24  31  
IaIs32 (L4440 RNAi) 23.3 ± 0.5 32 36 48 <0.0001 
N2 (pdhk-2 RNAi) 20.4 ± 0.6 26  36  
IaIs32 (pdhk-2 RNAi) 19.3 ± 0.7 26 -4 40 0.40 
N2 (L4440 RNAi) 16.8 ± 0.8 28  44  
IaIs32 (L4440 RNAi) 22.8 ± 0.8 30 36 44 <0.0001 
N2 (pdhk-2 RNAi) 20.1 ± 0.5 26  36  
IaIs32 (pdhk-2 RNAi) 21.9 ± 0.4 26 9 38 0.54 
N2 (L4440 RNAi) 19.4 ± 0.8 28  39  
IaIs32 (L4440 RNAi) 23.1 ± 0.5 28 19 42 0.015 
N2 (pdhk-2 RNAi) 20.7 ± 0.6 28  42  
IaIs32 (pdhk-2 RNAi) 19.5 ± 0.8 28 -6 43 0.29 
These lifespan assays were performed at 20ºC.   
† The p value was calculated by log-rank test as a comparison to N2 worms treated with 
control RNAi (L4440). 
 
Table 2: hif-1 is involved in the longevity of SIR2 over-expression 
worms. 
strain 
Adult life span 
mean +S.E. 
Maximum 
lifespan 
Percentage 
v. control  n p† value 
SIR2.1 O/E  23.9 ± 1.0 38  43  
SIR2.1O/E;hif-1(ia04) 19.6 ± 1.1 32 -18 34 0.008 
SIR2.1O/E;vhl-1(ok161) 28.0 ± 1.8 48 17 44 0.005 
SIR2.1 O/E  22.0 ± 0.8 36  45  
SIR2.1O/E;hif-1(ia04) 19.5 ± 0.7 30 -11 35 0.027 
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SIR2.1O/E;vhl-1(ok161) 28.2 ± 1.1 50 26 45 <0.0001 
SIR2.1 O/E  22.8 ± 0.8 40  46  
SIR2.1O/E;hif-1(ia04) 20.4 ± 0.9 34 -11 36 0.04 
SIR2.1O/E;vhl-1(ok161) 29.0 ± 1.1 50 27 43 <0.0001 
† The p value was calculated by log-rank test as a comparison to SIR2.1 over-expression 
(O/E) strains 
 
Table 3: Effects of bec-1 RNAi on the longevity of HIF-1 over-expression 
worms. 
strain 
Adult life span 
mean +S.E. 
Maximum 
lifespan 
Percentage 
v. control  n p† value 
N2 (L4440 RNAi) 18.4 ± 0.7 26  42  
IaIs32 (L4440 RNAi) 23.3 ± 0.6 30 27 46 <0.0001 
N2 (bec-1 RNAi) 17.1 ± 0.5 22  40  
IaIs32 (bec-1 RNAi) 17.5 ± 0.5 24 2 46 0.51 
† The p value was calculated by log-rank test as a comparison to N2 worms treated with 
RNAi. 
 
Table 4: Effects of bec-1 RNAi on the longevity of hypoxia treatment. 
Treatment 
Hypoxia life span 
mean +S.E. (n) 
Nomoxia life span 
mean+S.E. (n) 
Percentage v. 
normoxia p value† 
N2 (control RNAi) 18.0 ± 0.3 (43) 15.5 ± 0.4 (33) 16 <0.0001 
N2 (control RNAi) 18.9 ± 0.4 (48) 16.5 ± 0.3 (47) 15 <0.0001 
bec-1(RNAi) 14.5± 0.4 (38) 14.6 ± 0.4 (41) 0 0.96 
bec-1(RNAi) 15.5± 0.3 (48) 14.9 ± 0.3 (51) 4 0.10 
† The p value was calculated by log-rank test as a comparison between worms cultured in 
hypoxia and those cultured in normoxia. 
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